SS/JrHsdMcwi |
mean arterial blood pressure |
controlled sodium content diet (0.4 %) (for 28 days) then controlled sodium content diet (8 %) (for 30 days) and controlled exposure to ambient light (for 12 hours) |
Cowley AW Jr, et al., Physiol Genomics 2000 Apr 27;2(3):107-15. |
arterial blood pressure trait |
male |
91 days-93 days |
35 |
|
continuous mean |
173.0 |
mmHg |
7.0 |
41.41 |
vascular indwelling catheter method |
femoral artery |
259200.0 |
|
0 |
|
3 h per day |
decrease |
|
66140 |
229 |
SS/JrHsdMcwi |
absolute change in mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then norepinephrine (3 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101 days-103 days |
13 |
|
serial mean |
39.0 |
mmHg |
6.0 |
21.63 |
vascular indwelling catheter method |
left femoral artery |
0.0 |
|
0 |
|
|
|
|
67302 |
151 |
LH/MavRrrc |
absolute change in diastolic blood pressure |
trimethaphan camsylate (10 mg/kg) (for 0.2 hours) |
Vincent M, et al., J Clin Invest 1997 Oct 15;100(8):2000-6 |
arterial blood pressure trait |
not specified |
203 days-217 days |
16 |
|
serial mean |
-55.6 |
mmHg |
1.83 |
7.3 |
vascular indwelling catheter method |
abdominal aorta |
3600 |
|
0 |
|
|
|
|
65266 |
121 |
LN/MavRrrc |
absolute change in systolic blood pressure |
darodipine (200 ug/kg) (for 0.2 hours) |
Vincent M, et al., J Clin Invest 1997 Oct 15;100(8):2000-6 |
arterial blood pressure trait |
not specified |
203 days-217 days |
15 |
|
serial mean |
-62.1 |
mmHg |
3.69 |
14.3 |
vascular indwelling catheter method |
abdominal aorta |
3600 |
|
0 |
|
|
|
|
65267 |
121 |
LN/MavRrrc |
absolute change in diastolic blood pressure |
darodipine (200 ug/kg) (for 0.2 hours) |
Vincent M, et al., J Clin Invest 1997 Oct 15;100(8):2000-6 |
arterial blood pressure trait |
not specified |
203 days-217 days |
15 |
|
serial mean |
-40.9 |
mmHg |
3.02 |
11.7 |
vascular indwelling catheter method |
abdominal aorta |
3600 |
|
0 |
|
|
|
|
65269 |
121 |
SHR |
diastolic blood pressure |
control condition |
Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6. |
arterial blood pressure trait |
male |
99 days
| 23 |
|
continuous mean |
138.0 |
mmHg |
2.0 |
9.59 |
vascular indwelling catheter method |
femoral artery |
1800 |
|
0 |
|
pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH) |
|
|
65351 |
306 |
WKY/NCruk |
systolic blood pressure |
control condition |
Frantz S, et al., Hypertension 2001 Aug;38(2):216-21 |
arterial blood pressure trait |
male |
196 days
| 19 |
|
|
121.8 |
mmHg |
2.73 |
11.9 |
vascular indwelling catheter method |
|
|
|
0 |
|
beat to beat for 1 hour |
|
|
11324 |
72 |
WKY.SHR-(D1Wox19-D1Mit2)/Njs |
systolic blood pressure |
control condition |
Frantz S, et al., Hypertension 2001 Aug;38(2):216-21 |
arterial blood pressure trait |
male |
196 days
| 20 |
|
|
144.0 |
mmHg |
1.9 |
8.5 |
vascular indwelling catheter method |
|
|
|
0 |
|
beat to beat for 1 hour |
|
|
11325 |
72 |
WKY.SHR-(D1Rat56-D1M7Mit206)/Njs |
systolic blood pressure |
control condition |
Frantz S, et al., Hypertension 2001 Aug;38(2):216-21 |
arterial blood pressure trait |
male |
196 days
| 15 |
|
|
139.6 |
mmHg |
3.1 |
12.0 |
vascular indwelling catheter method |
|
|
|
0 |
|
beat to beat for 1 hour |
|
|
11326 |
72 |
WKY.SHR-(D1Rat236-D1M7Mit206)/Njs |
systolic blood pressure |
control condition |
Frantz S, et al., Hypertension 2001 Aug;38(2):216-21 |
arterial blood pressure trait |
male |
196 days
| 15 |
|
|
143.4 |
mmHg |
2.12 |
8.2 |
vascular indwelling catheter method |
|
|
|
0 |
|
beat to beat for 1 hour |
|
|
11327 |
72 |
SHR.WKY-(D1Wox34-D1Rat164)/Njs |
systolic blood pressure |
control condition |
Frantz S, et al., Hypertension 2001 Aug;38(2):216-21 |
arterial blood pressure trait |
male |
196 days
| 18 |
|
|
190.9 |
mmHg |
2.62 |
11.1 |
vascular indwelling catheter method |
|
|
|
0 |
|
beat to beat for 1 hour |
|
|
11330 |
72 |
SHR.WKY-(D1Wox34-Sah)/Njs |
systolic blood pressure |
control condition |
Frantz S, et al., Hypertension 2001 Aug;38(2):216-21 |
arterial blood pressure trait |
male |
196 days
| 20 |
|
|
179.2 |
mmHg |
3.15 |
14.1 |
vascular indwelling catheter method |
|
|
|
0 |
|
beat to beat for 1 hour |
|
|
11331 |
72 |
BN.GH-(D6Mit12-D6Rat15)/Mcwi |
mean arterial blood pressure |
control condition |
Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. |
arterial blood pressure trait |
male |
127 days-143 days |
16 |
|
serial mean |
97.3 |
mmHg |
2.75 |
11.0 |
vascular indwelling catheter method |
left femoral artery and vein |
4 hrs/day for 3 days |
|
0 |
|
microrenathane catheter; recover for 1 week after surgery |
|
|
11535 |
101 |
SS/JrHsdMcwi |
mean arterial blood pressure |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
92 days-94 days |
12 |
|
serial mean |
142.0 |
mmHg |
5.0 |
17.32 |
vascular indwelling catheter method |
left femoral artery |
0 |
|
0 |
|
|
|
|
65467 |
151 |
SS/JrHsdMcwi |
heart rate |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
heart pumping trait |
female |
93 days
| 12 |
|
serial mean |
427.0 |
beats/min |
6.0 |
20.78 |
vascular indwelling catheter method |
left femoral artery |
0 |
|
0 |
|
|
|
|
65469 |
151 |
LEW |
mean arterial blood pressure |
losartan (10 mg/kg) (for 0.2 hours) then pentolinium (5 mg/kg) (for 0.1 hours) |
Ueno T, et al., J Mol Med 2003 Jan;81(1):51-60. Epub 2002 Nov 21. |
arterial blood pressure trait |
both |
151 days-181 days |
21 |
|
continuous mean |
45.0 |
mmHg |
2.0 |
9.17 |
vascular indwelling catheter method |
carotid artery, jugular vein |
1800 |
|
0 |
|
|
|
|
64703 |
249 |
SS/JrHsdMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (0.4 %) (for 28 days) then controlled sodium content diet (8 %) (for 30 days) then controlled exposure to ambient light (for 12 hours) then controlled exposure to darkness (for 12 hours) |
Cowley AW Jr, et al., Physiol Genomics 2000 Apr 27;2(3):107-15. |
arterial blood pressure trait |
male |
91 days-93 days |
35 |
|
continuous mean |
7.0 |
mmHg |
7.0 |
41.41 |
vascular indwelling catheter method |
femoral artery |
0.0 |
|
0 |
|
left femoral artery |
decrease |
|
64931 |
229 |
HTG |
systolic blood pressure |
control condition |
Ueno T, et al., Physiol Genomics 2004 Mar 12;17(1):38-47. |
arterial blood pressure trait |
female |
151 days-181 days |
10 |
|
|
149.3 |
mmHg |
2.7 |
8.54 |
vascular indwelling catheter method |
carotid artery and jugular vein |
|
|
0 |
|
polyethylene catheter |
|
|
11713 |
120 |
LEW |
systolic blood pressure |
control condition |
Ueno T, et al., Physiol Genomics 2004 Mar 12;17(1):38-47. |
arterial blood pressure trait |
male |
151 days-181 days |
9 |
|
|
124.3 |
mmHg |
3.9 |
11.7 |
vascular indwelling catheter method |
carotid artery and jugular vein |
|
|
0 |
|
polyethylene catheter |
|
|
11715 |
120 |
LEW |
systolic blood pressure |
control condition |
Ueno T, et al., Physiol Genomics 2004 Mar 12;17(1):38-47. |
arterial blood pressure trait |
female |
151 days-181 days |
12 |
|
|
138.8 |
mmHg |
2.8 |
9.7 |
vascular indwelling catheter method |
carotid artery and jugular vein |
|
|
0 |
|
polyethylene catheter |
|
|
11717 |
120 |
LN/MavRrrc |
systolic blood pressure |
control condition |
Vincent M, et al., J Clin Invest 1997 Oct 15;100(8):2000-6 |
arterial blood pressure trait |
not specified |
203 days-217 days |
15 |
|
serial mean |
134.0 |
mmHg |
1.68 |
6.5 |
vascular indwelling catheter method |
abdominal aorta |
3600 |
|
0 |
|
|
|
|
11719 |
121 |
BN.GH-(D2Rat22-D2Mgh11)/Mcwi |
heart rate |
control condition |
Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. |
heart pumping trait |
male |
127 days-143 days |
19 |
|
serial mean |
349.8 |
beats/min |
7.34 |
32.0 |
vascular indwelling catheter method |
left femoral artery and vein |
4 hrs/day for 3 days |
|
0 |
|
microrenathane catheter; recover for 1 week after surgery |
|
|
11531 |
101 |
SHR |
systolic blood pressure |
controlled sodium content drinking water (1 %) (for 15 days) |
Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6. |
arterial blood pressure trait |
male |
99 days
| 24 |
|
continuous mean |
196.6 |
mmHg |
3.2 |
15.68 |
vascular indwelling catheter method |
femoral artery |
1800 |
|
0 |
|
pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH) |
|
|
12749 |
306 |
SHR.BN-(D2Rat226-D2Rat294)/Jk |
systolic blood pressure |
controlled sodium content drinking water (1 %) (for 15 days) |
Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6. |
arterial blood pressure trait |
male |
99 days
| 22 |
|
continuous mean |
177.6 |
mmHg |
2.0 |
9.38 |
vascular indwelling catheter method |
femoral artery |
1800 |
|
0 |
|
pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH) |
|
|
12751 |
306 |
SHR.WKY-(D1Wox19-D1Wox34)/Njs |
systolic blood pressure |
control condition |
Frantz SA, et al., Hypertension 1998 Oct;32(4):639-46 |
arterial blood pressure trait |
male |
175 days
| 31 |
|
continuous mean |
220.9 |
mmHg |
2.57 |
14.3 |
vascular indwelling catheter method |
aorta |
|
|
0 |
|
|
|
|
11908 |
206 |
BN/NHsdMcwi |
mean arterial blood pressure |
controlled sodium content diet (0.1 %) (for 28 days) then controlled sodium content diet (8 %) (for 31 days) and controlled exposure to ambient light (for 12 hours) |
Cowley AW Jr, et al., Physiol Genomics 2000 Apr 27;2(3):107-15. |
arterial blood pressure trait |
male |
91 days-94 days |
42 |
|
continuous mean |
109.0 |
mmHg |
2.0 |
12.96 |
vascular indwelling catheter method |
femoral artery |
259200.0 |
|
0 |
|
3 h per day |
|
|
12012 |
229 |
BN/NHsdMcwi |
mean arterial blood pressure |
controlled sodium content diet (0.1 %) (for 28 days) then controlled sodium content diet (8 %) (for 30 days) and controlled exposure to darkness (for 12 hours) |
Cowley AW Jr, et al., Physiol Genomics 2000 Apr 27;2(3):107-15. |
arterial blood pressure trait |
male |
91 days-93 days |
42 |
|
continuous mean |
114.0 |
mmHg |
4.0 |
25.92 |
vascular indwelling catheter method |
femoral artery |
14400.0 |
|
0 |
|
left femoral artery |
|
|
12016 |
229 |
BN.GH-(D2Rat22-D2Mgh11)/Mcwi |
diastolic blood pressure |
control condition |
Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. |
arterial blood pressure trait |
male |
127 days-143 days |
19 |
|
serial mean |
86.9 |
mmHg |
2.23 |
9.7 |
vascular indwelling catheter method |
left femoral artery and vein |
4 hrs/day for 3 days |
|
0 |
|
microrenathane catheter; recover for 1 week after surgery |
|
|
11530 |
101 |
HTG |
mean arterial blood pressure |
control condition |
Ueno T, et al., J Mol Med 2003 Jan;81(1):51-60. Epub 2002 Nov 21. |
arterial blood pressure trait |
both |
151 days-181 days |
19 |
|
continuous mean |
125.0 |
mmHg |
3.0 |
13.08 |
vascular indwelling catheter method |
carotid artery, jugular vein |
1800 |
|
0 |
|
|
|
|
12391 |
249 |
WKY/Bbb |
heart rate |
control condition |
Kreutz R, et al., Circulation 1997 Aug 19;96(4):1078-81. |
heart pumping trait |
female |
112 days
| 12 |
|
serial mean |
408.0 |
beats/min |
8.95 |
31.0 |
vascular indwelling catheter method |
femoral artery |
|
|
0 |
|
|
3 sets of readings per day for two days |
|
13284 |
334 |
WKY/Bbb |
heart rate |
controlled sodium content drinking water (1 %) (between 13 and 15 days) |
Kreutz R, et al., Circulation 1997 Aug 19;96(4):1078-81. |
heart pumping trait |
female |
125 days-127 days |
10 |
|
serial mean |
380.0 |
beats/min |
11.07 |
35.0 |
vascular indwelling catheter method |
femoral artery |
|
|
0 |
|
|
3 sets of readings per day for two days |
|
13287 |
334 |
SS/JrHsdMcwi |
heart rate |
controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (for 21 days) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
heart pumping trait |
female |
89 days-92 days |
20 |
|
serial mean |
437.0 |
beats/min |
6.0 |
26.83 |
vascular indwelling catheter method |
left femoral artery |
|
|
0 |
|
|
|
|
13310 |
151 |
SHR.BN-(D2Rat226-D2Rat294)/Jk |
diastolic blood pressure |
control condition |
Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6. |
arterial blood pressure trait |
male |
99 days
| 22 |
|
continuous mean |
127.0 |
mmHg |
3.0 |
14.07 |
vascular indwelling catheter method |
femoral artery |
1800 |
|
0 |
|
pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH) |
|
|
65399 |
306 |
SHR.BN-(D2Rat226-D2Rat294)/Jk |
mean arterial blood pressure |
control condition |
Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6. |
arterial blood pressure trait |
male |
99 days
| 22 |
|
continuous mean |
148.0 |
mmHg |
2.0 |
9.38 |
vascular indwelling catheter method |
femoral artery |
1800 |
|
0 |
|
pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH) |
|
|
65401 |
306 |
SHR.BN-(D4Rat33-D4Rat54)/Jk |
diastolic blood pressure |
controlled sodium content drinking water (1 %) (for 15 days) |
Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6. |
arterial blood pressure trait |
male |
99 days
| 23 |
|
continuous mean |
136.0 |
mmHg |
2.0 |
9.59 |
vascular indwelling catheter method |
femoral artery |
1800 |
|
0 |
|
pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH) |
|
|
65408 |
306 |
SHR.BN-(D16Rat87-D16Mgh1)/Jk |
diastolic blood pressure |
controlled sodium content drinking water (1 %) (for 15 days) |
Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6. |
arterial blood pressure trait |
male |
99 days
| 23 |
|
continuous mean |
130.0 |
mmHg |
3.0 |
14.39 |
vascular indwelling catheter method |
femoral artery |
1800 |
|
0 |
|
pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH) |
|
|
65414 |
306 |
SHR.BN-(D16Rat87-D16Mgh1)/Jk |
mean arterial blood pressure |
controlled sodium content drinking water (1 %) (for 15 days) |
Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6. |
arterial blood pressure trait |
male |
99 days
| 23 |
|
continuous mean |
154.0 |
mmHg |
3.0 |
14.39 |
vascular indwelling catheter method |
femoral artery |
1800 |
|
0 |
|
pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH) |
|
|
65415 |
306 |
SHR.BN-(D2Rat226-D2Rat294)/Jk |
heart rate |
controlled sodium content diet (1 %) (for 14 days) |
Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6. |
heart pumping trait |
male |
87 days
| 22 |
|
continuous mean |
350.0 |
beats/min |
4.0 |
18.76 |
vascular indwelling catheter method |
femoral artery |
1800 |
|
0 |
|
pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH) |
|
|
65421 |
306 |
LH/MavRrrc |
absolute change in systolic blood pressure |
losartan (20 mg/kg) (for 0.7 hours) |
Vincent M, et al., J Clin Invest 1997 Oct 15;100(8):2000-6 |
arterial blood pressure trait |
not specified |
203 days-217 days |
16 |
|
serial mean |
-6.31 |
mmHg |
2.58 |
10.33 |
vascular indwelling catheter method |
abdominal aorta |
3600 |
|
0 |
|
|
|
|
65260 |
121 |
BN-Lx/Cub |
diastolic blood pressure |
control condition |
Pravenec M, et al., J Hypertens 1989 Mar;7(3):217-21. |
arterial blood pressure trait |
male |
0 days
| 8 |
|
|
93.0 |
mmHg |
3.0 |
8.49 |
vascular indwelling catheter method |
carotid artery segment |
0.0 |
|
0 |
|
|
|
|
66037 |
651 |
F344/NHsd |
mean arterial blood pressure |
control condition |
Zhao L et al., 2001, Circulation, 103(3), 442-7 |
arterial blood pressure trait |
male |
105 days
| 12 |
|
median |
121.0 |
mmHg |
|
|
vascular indwelling catheter method |
left common carotid artery |
0 |
|
0 |
|
|
|
|
66127 |
102 |
WKY/NCruk |
mean arterial blood pressure |
control condition |
Zhao L et al., 2001, Circulation, 103(3), 442-7 |
arterial blood pressure trait |
male |
105 days
| 12 |
|
median |
91.0 |
mmHg |
|
|
vascular indwelling catheter method |
left common carotid artery |
0 |
|
0 |
|
|
|
|
66129 |
102 |
BN.GH-(D2Rat22-D2Mgh11)/Mcwi |
change in mean arterial blood pressure to change in vasoactive chemical dose ratio |
angiotensin II (5-50 ng/kg/min) (between 0.2 and 1 hours) |
Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. |
arterial blood pressure trait |
male |
130 days-144 days |
11 |
|
|
0.66 |
mmHg/ng/kg/min |
0.03 |
0.09 |
vascular indwelling catheter method |
left femoral artery and vein |
0.0 |
|
0 |
|
microrenathane catheter; recover for 1 week after surgery |
slope of map response curve |
|
68340 |
101 |
SHRSP/Izm |
heart rate |
control condition |
Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. |
heart pumping trait |
male |
98 days
| 6 |
|
|
287.0 |
beats/min |
5.0 |
12.25 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
69088 |
1120 |
WKY.WKHA-(D5Rat45-D5Rat245)/Cfd |
time constant of left ventricular pressure decay |
sham surgical control condition |
Souzeau E, et al., Hypertension. 2006 Jan;47(1):128-33. Epub 2005 Dec 12. |
heart left ventricular blood pressure trait |
male |
84 days-154 days |
5 |
|
|
7.5 |
ms |
0.6 |
1.34 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
68918 |
1014 |
SS/JrHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101 days-103 days |
13 |
|
serial mean |
126.0 |
mmHg |
4.1 |
14.78 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
0 |
|
|
|
|
69528 |
151 |
BN/NHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then angiotensin II (100 ng/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101 days-103 days |
21 |
|
serial mean |
132.9 |
mmHg |
3.8 |
17.41 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
0 |
|
|
|
|
69531 |
151 |
BN/NHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then angiotensin II (200 ng/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101 days-103 days |
21 |
|
serial mean |
139.1 |
mmHg |
3.6 |
16.5 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
0 |
|
|
|
|
69533 |
151 |
SS/JrHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then norepinephrine (0.5 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101 days-103 days |
13 |
|
serial mean |
141.7 |
mmHg |
7.4 |
26.68 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
0 |
|
|
|
|
69536 |
151 |
Crl:WI |
systolic blood pressure |
controlled NG-nitroarginine methyl ester content drinking water (20 mg/kg/d) (between 0 and 672 hours) |
Blanc J, et al., J Hypertens. 1999 Nov;17(11):1527-34. |
arterial blood pressure trait |
male |
0 days
| 15 |
|
|
185.0 |
mmHg |
5.0 |
19.36 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
70417 |
1418 |
WKY/Cfd |
left ventricular end-systolic blood pressure |
artificial aortocaval fistula |
Souzeau E, et al., Hypertension. 2006 Jan;47(1):128-33. Epub 2005 Dec 12. |
heart left ventricular blood pressure trait |
male |
84 days-154 days |
5 |
|
|
115.5 |
mmHg |
4.4 |
9.84 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
68862 |
1014 |
WKY.WKHA-(D5Rat45-D5Rat245)/Cfd |
left ventricular end-systolic blood pressure |
artificial aortocaval fistula |
Souzeau E, et al., Hypertension. 2006 Jan;47(1):128-33. Epub 2005 Dec 12. |
heart left ventricular blood pressure trait |
male |
84 days-154 days |
5 |
|
|
134.3 |
mmHg |
5.9 |
13.19 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
68866 |
1014 |
WKY.WKHA-(D5Rat45-D5Rat245)/Cfd |
left ventricular end-systolic blood pressure |
sham surgical control condition |
Souzeau E, et al., Hypertension. 2006 Jan;47(1):128-33. Epub 2005 Dec 12. |
heart left ventricular blood pressure trait |
female |
84 days-154 days |
5 |
|
|
120.3 |
mmHg |
2.4 |
5.37 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
68872 |
1014 |
WKHA/Cfd |
maximum rate of positive change in left ventricular blood pressure |
artificial aortocaval fistula |
Souzeau E, et al., Hypertension. 2006 Jan;47(1):128-33. Epub 2005 Dec 12. |
heart left ventricular blood pressure trait |
female |
84 days-154 days |
5 |
|
|
10070.0 |
mmHg/s |
611.0 |
1366.24 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
68899 |
1014 |
WKY.WKHA-(D5Rat45-D5Rat245)/Cfd |
maximum rate of positive change in left ventricular blood pressure |
sham surgical control condition |
Souzeau E, et al., Hypertension. 2006 Jan;47(1):128-33. Epub 2005 Dec 12. |
heart left ventricular blood pressure trait |
female |
84 days-154 days |
5 |
|
|
9210.0 |
mmHg/s |
296.0 |
661.88 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
68900 |
1014 |
SS/JrHsdMcwi |
diastolic blood pressure |
controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (between 22 and 24 days) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
93 days
| 10 |
|
serial mean |
146.5 |
mmHg |
5.6 |
17.71 |
vascular indwelling catheter method |
left femoral artery |
10800.0 |
|
0 |
|
|
|
|
69518 |
151 |
SS/JrHsdMcwi |
heart rate |
controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (between 22 and 24 days) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
heart pumping trait |
female |
93 days
| 11 |
|
serial mean |
446.8 |
beats/min |
9.7 |
32.17 |
vascular indwelling catheter method |
left femoral artery |
10800.0 |
|
0 |
|
|
|
|
69520 |
151 |
WKY/NCrl |
systolic blood pressure |
controlled exposure to ambient light (for 12 hours) |
Iwai N, et al., Circulation 1999 Nov 2;100(18):1923-9. |
arterial blood pressure trait |
male |
112 days
| 7 |
|
|
125.9 |
mmHg |
0.49 |
1.3 |
vascular indwelling catheter method |
left common carotid artery |
0.0 |
|
0 |
|
|
daytime (7 AM - 7 PM) |
|
70081 |
1281 |
WKY/NCrl |
systolic blood pressure |
controlled exposure to darkness (for 12 hours) |
Iwai N, et al., Circulation 1999 Nov 2;100(18):1923-9. |
arterial blood pressure trait |
male |
112 days
| 7 |
|
|
130.0 |
mmHg |
0.57 |
1.5 |
vascular indwelling catheter method |
left common carotid artery |
0.0 |
|
0 |
|
|
nighttime (7 PM - 7 AM) |
|
70082 |
1281 |
WKY.SHR-(D1Mgh14-D1Rat77)/Iwai |
diastolic blood pressure |
controlled sodium content diet (8 %) (for 14 days) then controlled exposure to ambient light (for 12 hours) |
Iwai N, et al., Circulation 1999 Nov 2;100(18):1923-9. |
arterial blood pressure trait |
male |
126 days
| 8 |
|
|
90.6 |
mmHg |
1.27 |
3.6 |
vascular indwelling catheter method |
left common carotid artery |
0.0 |
|
0 |
|
|
daytime (7 AM - 7 PM) |
|
70095 |
1281 |
Crl:CD(SD) |
mean arterial blood pressure |
control condition |
O'Meara CC, et al., Physiol Genomics. 2012 Aug 1;44(15):741-53. doi: 10.1152/physiolgenomics.00187.2011. Epub 2012 Jun 5. |
arterial blood pressure trait |
male |
189 days
| 6 |
|
serial mean |
93.0 |
mmHg |
5.0 |
12.25 |
vascular indwelling catheter method |
femoral artery |
10800.0 |
|
0 |
|
1day/week |
|
|
96901 |
1738 |
SHRSP/Izm |
percent change in mean arterial blood pressure |
air-jet exposure (for 0 hours) |
Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. |
arterial blood pressure trait |
male |
98 days
| 6 |
|
|
28.0 |
% |
2.0 |
4.9 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
84544 |
1120 |
WKY/Izm |
heart rate |
control condition |
Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. |
heart pumping trait |
male |
98 days
| 6 |
|
|
306.0 |
beats/min |
12.0 |
29.39 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
84549 |
1120 |
WKY/Izm |
absolute change in mean arterial blood pressure |
air-jet exposure (for 0 hours) |
Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. |
arterial blood pressure trait |
male |
98 days
| 6 |
|
|
23.0 |
mmHg |
2.0 |
4.9 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
84556 |
1120 |
WKY.SHRSP-(D1Wox29-D1Arb21)/Izm |
absolute change in heart rate |
air-jet exposure (for 0 hours) |
Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. |
heart pumping trait |
male |
98 days
| 6 |
|
|
105.0 |
beats/min |
12.0 |
29.39 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
84559 |
1120 |
WKY/Izm |
absolute change in mean arterial blood pressure |
vehicle control condition (2 ul) (for 0 hours) then air-jet exposure (for 0 hours) then angiotensin II (20 ng) |
Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. |
arterial blood pressure trait |
male |
98 days
| 6 |
|
|
27.0 |
mmHg |
3.0 |
7.35 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
84566 |
1120 |
SD-Trpv1em1Sage+/+ |
heart rate |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion (for 0.2 hours) then V1-Cal (1 mg/kg) (for 0.9 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
heart pumping trait |
male |
56 days-70 days |
6 |
|
|
432.0 |
beats/min |
10.0 |
24.49 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
104773 |
2988 |
SD-Trpv1em1Sage+/+ |
mean arterial blood pressure |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion (for 0.2 hours) then V1-Cal (1 mg/kg) (for 0.9 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
arterial blood pressure trait |
male |
56 days-70 days |
6 |
|
|
110.0 |
mmHg |
5.0 |
12.25 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
104779 |
2988 |
SD-Trpv1em1Sage-/- |
mean arterial blood pressure |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion (for 0.2 hours) then V1-Cal (1 mg/kg) (for 0.9 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
arterial blood pressure trait |
male |
56 days-70 days |
6 |
|
|
114.0 |
mmHg |
7.0 |
17.15 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
104782 |
2988 |
SD-Trpv1em1Sage+/+ |
heart rate |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion (for 0.5 hours) then dihydrocapsaicin (0.3 mg/kg) (for 3.2 hours) then Myocardial reperfusion (for 2 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
heart pumping trait |
male |
56 days-70 days |
6 |
|
|
363.0 |
beats/min |
9.0 |
22.05 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
104796 |
2988 |
SD-Trpv1em1Sage+/+ |
heart rate |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion (for 0.5 hours) then V1-Cal (1 mg/kg) (for 3.2 hours) then Myocardial reperfusion (for 2 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
heart pumping trait |
male |
56 days-70 days |
6 |
|
|
400.0 |
beats/min |
8.0 |
19.6 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
104797 |
2988 |
SD-Trpv1em1Sage+/+ |
heart rate |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion then Capsazepine (3 mg/kg) (for 0.7 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
heart pumping trait |
male |
56 days-70 days |
5 |
|
|
366.0 |
beats/min |
7.0 |
15.65 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
104673 |
2988 |
SD-Trpv1em1Sage+/+ |
heart rate |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion (for 0.2 hours) then dihydrocapsaicin (0.1 mg/kg) (for 0.9 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
heart pumping trait |
male |
56 days-70 days |
6 |
|
|
373.0 |
beats/min |
10.0 |
24.49 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
104694 |
2988 |
SD-Trpv1em1Sage+/+ |
heart rate |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion (for 0.5 hours) then dihydrocapsaicin (0.3 mg/kg) (for 3.2 hours) and Capsazepine (3 mg/kg) (for 3.2 hours) then Myocardial reperfusion (for 2 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
heart pumping trait |
male |
56 days-70 days |
6 |
|
|
383.0 |
beats/min |
16.0 |
39.19 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
104707 |
2988 |
SD-Trpv1em1Sage+/+ |
heart rate |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion (for 0.5 hours) then dihydrocapsaicin (0.3 mg/kg) (for 3.2 hours) and cyclosporine A (2.5 mg/kg) (for 3.2 hours) then Myocardial reperfusion (for 2 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
heart pumping trait |
male |
56 days-70 days |
6 |
|
|
409.0 |
beats/min |
14.0 |
34.29 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
104708 |
2988 |
SD-Trpv1em1Sage+/+ |
heart rate |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion (for 0.5 hours) then cyclosporine A (2.5 mg/kg) (for 3.2 hours) then Myocardial reperfusion (for 2 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
heart pumping trait |
male |
56 days-70 days |
6 |
|
|
399.0 |
beats/min |
14.0 |
34.29 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
104710 |
2988 |
SD-Trpv1em1Sage+/+ |
mean arterial blood pressure |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion (for 0.2 hours) then Capsazepine (3 mg/kg) (for 0.9 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
arterial blood pressure trait |
male |
56 days-70 days |
5 |
|
|
108.0 |
mmHg |
12.0 |
26.83 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
104718 |
2988 |
SD-Trpv1em1Sage+/+ |
mean arterial blood pressure |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion (for 0.5 hours) then dihydrocapsaicin (0.3 mg/kg) (for 3.2 hours) and cyclosporine A (2.5 mg/kg) (for 3.2 hours) then Myocardial reperfusion (for 2 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
arterial blood pressure trait |
male |
56 days-70 days |
6 |
|
|
68.0 |
mmHg |
3.0 |
7.35 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
104726 |
2988 |
SD-Trpv1em1Sage-/- |
mean arterial blood pressure |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
arterial blood pressure trait |
male |
56 days-70 days |
6 |
|
|
122.0 |
mmHg |
5.0 |
12.25 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
104757 |
2988 |
MWF/Hsd |
mean arterial blood pressure |
sham surgical control condition |
Szymanski MK, etal., Basic Res Cardiol. 2012 Mar;107(2):242. doi: 10.1007/s00395-011-0242-4. Epub 2012 Jan 19. |
arterial blood pressure trait |
male |
84 days
| 5 |
|
|
102.0 |
mmHg |
3.0 |
6.71 |
vascular indwelling catheter method |
aorta |
0.0 |
|
0 |
|
|
|
|
108773 |
3130 |
MWF/Hsd |
left ventricular end-diastolic blood pressure |
sham surgical control condition |
Szymanski MK, etal., Basic Res Cardiol. 2012 Mar;107(2):242. doi: 10.1007/s00395-011-0242-4. Epub 2012 Jan 19. |
heart left ventricular blood pressure trait |
male |
84 days
| 5 |
|
|
6.2 |
mmHg |
1.9 |
4.25 |
vascular indwelling catheter method |
heart left ventricle |
0.0 |
|
0 |
|
|
|
|
108777 |
3130 |
HsdCpb:WU |
heart rate |
sham surgical control condition |
Szymanski MK, etal., Basic Res Cardiol. 2012 Mar;107(2):242. doi: 10.1007/s00395-011-0242-4. Epub 2012 Jan 19. |
heart pumping trait |
male |
84 days
| 5 |
|
|
359.0 |
beats/min |
18.0 |
40.25 |
vascular indwelling catheter method |
heart |
0.0 |
|
0 |
|
|
|
|
108778 |
3130 |
MWF/Hsd |
central venous pressure |
sham surgical control condition |
Szymanski MK, etal., Basic Res Cardiol. 2012 Mar;107(2):242. doi: 10.1007/s00395-011-0242-4. Epub 2012 Jan 19. |
venous blood pressure trait |
male |
84 days
| 5 |
|
|
2.1 |
mmHg |
1.7 |
3.8 |
vascular indwelling catheter method |
vena cava |
0.0 |
|
0 |
|
|
|
|
108781 |
3130 |
HsdCpb:WU |
maximum rate of positive change in left ventricular blood pressure |
sham surgical control condition |
Szymanski MK, etal., Basic Res Cardiol. 2012 Mar;107(2):242. doi: 10.1007/s00395-011-0242-4. Epub 2012 Jan 19. |
heart left ventricular blood pressure trait |
male |
175 days
| 10 |
|
|
9091.0 |
mmHg/s |
299.0 |
945.52 |
vascular indwelling catheter method |
heart left ventricle |
0.0 |
|
0 |
|
|
|
|
108850 |
3130 |
MWF/Hsd |
maximum rate of positive change in left ventricular blood pressure |
left anterior descending coronary artery occlusion |
Szymanski MK, etal., Basic Res Cardiol. 2012 Mar;107(2):242. doi: 10.1007/s00395-011-0242-4. Epub 2012 Jan 19. |
heart left ventricular blood pressure trait |
male |
175 days
| 10 |
|
|
8452.0 |
mmHg/s |
455.0 |
1438.84 |
vascular indwelling catheter method |
heart left ventricle |
0.0 |
|
0 |
|
|
|
|
108853 |
3130 |
HsdCpb:WU |
systemic vascular resistance |
left anterior descending coronary artery occlusion |
Szymanski MK, etal., Basic Res Cardiol. 2012 Mar;107(2):242. doi: 10.1007/s00395-011-0242-4. Epub 2012 Jan 19. |
arterial blood pressure trait |
male |
168 days
| 6 |
|
|
0.95 |
mmHg/ml/min |
0.1 |
0.24 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
108891 |
3130 |
HsdCpb:WU |
systemic vascular resistance |
left anterior descending coronary artery occlusion |
Szymanski MK, etal., Basic Res Cardiol. 2012 Mar;107(2):242. doi: 10.1007/s00395-011-0242-4. Epub 2012 Jan 19. |
arterial blood pressure trait |
male |
168 days
| 10 |
|
|
1.04 |
mmHg/ml/min |
0.18 |
0.57 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
108893 |
3130 |
HsdCpb:WU |
renal vascular resistance |
sham surgical control condition |
Szymanski MK, etal., Basic Res Cardiol. 2012 Mar;107(2):242. doi: 10.1007/s00395-011-0242-4. Epub 2012 Jan 19. |
arterial blood pressure trait |
male |
175 days
| 10 |
|
|
13.2 |
mmHg/ml/min |
1.9 |
6.01 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
108894 |
3130 |
MWF/Hsd |
renal vascular resistance |
left anterior descending coronary artery occlusion |
Szymanski MK, etal., Basic Res Cardiol. 2012 Mar;107(2):242. doi: 10.1007/s00395-011-0242-4. Epub 2012 Jan 19. |
arterial blood pressure trait |
male |
175 days
| 10 |
|
|
39.5 |
mmHg/ml/min |
6.9 |
21.82 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
108896 |
3130 |
HsdCpb:WU |
renal vascular resistance |
left anterior descending coronary artery occlusion |
Szymanski MK, etal., Basic Res Cardiol. 2012 Mar;107(2):242. doi: 10.1007/s00395-011-0242-4. Epub 2012 Jan 19. |
arterial blood pressure trait |
male |
175 days
| 6 |
|
|
13.5 |
mmHg/ml/min |
1.3 |
3.18 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
108897 |
3130 |
MWF/Hsd |
renal vascular resistance |
control condition |
Szymanski MK, etal., Basic Res Cardiol. 2012 Mar;107(2):242. doi: 10.1007/s00395-011-0242-4. Epub 2012 Jan 19. |
arterial blood pressure trait |
male |
84 days
| 5 |
|
|
47.0 |
mmHg/ml/min |
12.0 |
26.83 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
108899 |
3130 |
HsdCpb:WU |
heart rate |
sham surgical control condition |
Szymanski MK, etal., Basic Res Cardiol. 2012 Mar;107(2):242. doi: 10.1007/s00395-011-0242-4. Epub 2012 Jan 19. |
heart pumping trait |
male |
175 days
| 10 |
|
|
331.0 |
beats/min |
14.0 |
44.27 |
vascular indwelling catheter method |
heart |
0.0 |
|
0 |
|
|
|
|
108838 |
3130 |
HsdCpb:WU |
mean arterial blood pressure |
sham surgical control condition |
Szymanski MK, etal., Basic Res Cardiol. 2012 Mar;107(2):242. doi: 10.1007/s00395-011-0242-4. Epub 2012 Jan 19. |
arterial blood pressure trait |
male |
175 days
| 10 |
|
|
94.0 |
mmHg |
3.0 |
9.49 |
vascular indwelling catheter method |
aorta |
0.0 |
|
0 |
|
|
|
|
108842 |
3130 |
MWF/Hsd |
mean arterial blood pressure |
sham surgical control condition |
Szymanski MK, etal., Basic Res Cardiol. 2012 Mar;107(2):242. doi: 10.1007/s00395-011-0242-4. Epub 2012 Jan 19. |
arterial blood pressure trait |
male |
175 days
| 9 |
|
|
107.0 |
mmHg |
4.0 |
12.0 |
vascular indwelling catheter method |
aorta |
0.0 |
|
0 |
|
|
|
|
108844 |
3130 |
MWF/Hsd |
mean arterial blood pressure |
left anterior descending coronary artery occlusion |
Szymanski MK, etal., Basic Res Cardiol. 2012 Mar;107(2):242. doi: 10.1007/s00395-011-0242-4. Epub 2012 Jan 19. |
arterial blood pressure trait |
male |
175 days
| 10 |
|
|
84.0 |
mmHg |
5.0 |
15.81 |
vascular indwelling catheter method |
aorta |
0.0 |
|
0 |
|
|
|
|
108845 |
3130 |
SR/Hsd |
range of heart rate variation during variation of mean arterial blood pressure |
artificial cerebrospinal fluid with 0.15 M sodium (4.4-4.6 ul/hr) (for 14 days) |
Huang BS, et al., Am J Physiol Heart Circ Physiol. 2005 Feb;288(2):H517-24. doi: 10.1152/ajpheart.00651.2004. Epub 2004 Sep 30. |
heart pumping trait |
male |
52 days-61 days |
6 |
|
|
211.0 |
beats/min |
18.0 |
44.09 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
change in heart rate to change in mean arterial blood pressure ratio (range) (CMO:0003896) |
|
138430 |
2801 |
SR/Hsd |
mean arterial pressure at the midpoint of a range of renal sympathetic nerve activity |
aldosterone (22.5 ng/hr) (for 14 days) and artificial cerebrospinal fluid with 0.15 M sodium (4.4-4.6 ul/hr) (for 14 days) |
Huang BS, et al., Am J Physiol Heart Circ Physiol. 2005 Feb;288(2):H517-24. doi: 10.1152/ajpheart.00651.2004. Epub 2004 Sep 30. |
arterial blood pressure trait |
male |
52 days-61 days |
8 |
|
|
109.0 |
mmHg |
3.0 |
8.49 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
138428 |
2801 |
SS/Hsd |
heart rate |
artificial cerebrospinal fluid with 0.14 M sodium (4.4-4.6 ul/hr) (for 14 days) and aldosterone (22.5 ng/hr) (for 14 days) |
Huang BS, et al., Am J Physiol Heart Circ Physiol. 2005 Feb;288(2):H517-24. doi: 10.1152/ajpheart.00651.2004. Epub 2004 Sep 30. |
heart pumping trait |
male |
49 days-57 days |
0 |
|
|
465.0 |
beats/min |
10.0 |
|
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
138451 |
2801 |
MWF |
mean arterial blood pressure |
cyclosporine A (50 mg/kg/d) (for 7 days) |
Fassi A, etal., Am J Kidney Dis. 1999 Feb;33(2):267-75. doi: 10.1016/s0272-6386(99)70299-4. |
arterial blood pressure trait |
male |
133 days-147 days |
6 |
|
|
110.0 |
mmHg |
3.67 |
9.0 |
vascular indwelling catheter method |
femoral artery |
0.0 |
|
0 |
|
|
|
|
110077 |
3163 |
SS/Hsd |
mean arterial blood pressure |
artificial cerebrospinal fluid with 0.15 M sodium (4.4-4.6 ul/hr) (for 14 days) |
Huang BS, et al., Am J Physiol Heart Circ Physiol. 2005 Feb;288(2):H517-24. doi: 10.1152/ajpheart.00651.2004. Epub 2004 Sep 30. |
arterial blood pressure trait |
male |
52 days-61 days |
0 |
|
|
108.0 |
mmHg |
2.0 |
|
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
138368 |
2801 |
SS/Hsd |
percent change in heart rate |
artificial cerebrospinal fluid with 0.15 M sodium (4.4-4.6 ul/hr) (for 14 days) then air-jet exposure (1-1.5 lb/in2) (for 0 hours) |
Huang BS, et al., Am J Physiol Heart Circ Physiol. 2005 Feb;288(2):H517-24. doi: 10.1152/ajpheart.00651.2004. Epub 2004 Sep 30. |
heart pumping trait |
male |
49 days-56 days |
0 |
|
|
4.0 |
% |
0.2 |
|
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
138370 |
2801 |
SR/Hsd |
mean arterial pressure at the midpoint of a range of heart rates |
aldosterone (22.5 ng/hr) (for 14 days) and artificial cerebrospinal fluid with 0.15 M sodium (4.4-4.6 ul/hr) (for 14 days) |
Huang BS, et al., Am J Physiol Heart Circ Physiol. 2005 Feb;288(2):H517-24. doi: 10.1152/ajpheart.00651.2004. Epub 2004 Sep 30. |
arterial blood pressure trait |
male |
52 days-61 days |
8 |
|
|
108.0 |
mmHg |
3.0 |
8.49 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
138439 |
2801 |
SS/Hsd |
mean arterial blood pressure |
aldosterone (22.5 ng/hr) (for 14 days) and artificial cerebrospinal fluid with 0.15 M sodium (4.4-4.6 ul/hr) (for 14 days) |
Huang BS, et al., Am J Physiol Heart Circ Physiol. 2005 Feb;288(2):H517-24. doi: 10.1152/ajpheart.00651.2004. Epub 2004 Sep 30. |
arterial blood pressure trait |
male |
52 days-61 days |
0 |
|
|
131.0 |
mmHg |
3.0 |
|
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
138447 |
2801 |
LH/Mav |
diastolic blood pressure |
control condition |
Dubay C, et al., Nat Genet 1993 Apr;3(4):354-7 |
arterial blood pressure trait |
male |
203 days-217 days |
16 |
|
serial mean |
118.4 |
mmHg |
|
|
vascular indwelling catheter method |
abdominal aorta |
10800 |
|
0 |
|
|
|
|
11647 |
111 |
BN.GH-(D6Mit12-D6Rat15)/Mcwi |
diastolic blood pressure |
control condition |
Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. |
arterial blood pressure trait |
male |
127 days-143 days |
16 |
|
serial mean |
82.7 |
mmHg |
3.0 |
12.0 |
vascular indwelling catheter method |
left femoral artery and vein |
4 hrs/day for 3 days |
|
0 |
|
microrenathane catheter; recover for 1 week after surgery |
|
|
11537 |
101 |
BN/Elh |
change in heart rate to change in vasoactive chemical dose ratio |
angiotensin II (5-50 ng/kg/min) (between 0.2 and 1 hours) then norepinephrine (0.1-1 ug/kg/min) (between 0.2 and 1 hours) then phenylephrine (4 ug/kg) (between 0 and 0 hours) |
Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. |
heart pumping trait |
male |
132 days-146 days |
14 |
|
|
-2.28 |
(beats/min)/(ug/kg) |
0.07 |
0.26 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
ng/kg/min |
change in heart rate to change in vasoactive chemical dose ratio (CMO:0003904), (beats/min)/(ug/kg) |
|
138470 |
101 |
BN/NHsdMcwi |
absolute change in mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then norepinephrine (3 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101 days-103 days |
19 |
|
serial mean |
22.0 |
mmHg |
3.0 |
13.08 |
vascular indwelling catheter method |
left femoral artery |
0.0 |
|
0 |
|
|
|
|
67301 |
151 |
BN.GH-(D18Rat41-D18Mgh4)/Mcwi |
change in heart rate to change in vasoactive chemical dose ratio |
angiotensin II (5-50 ng/kg/min) (between 0.2 and 1 hours) then norepinephrine (0.1-1 ug/kg/min) (between 0.2 and 1 hours) then phenylephrine (4 ug/kg) (between 0 and 0 hours) |
Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. |
heart pumping trait |
male |
132 days-146 days |
11 |
|
|
-1.25 |
(beats/min)/(ug/kg) |
0.05 |
0.17 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
ng/kg/min |
change in heart rate to change in vasoactive chemical dose ratio (CMO:0003904), (beats/min)/(ug/kg) |
|
138469 |
101 |
BN/Elh |
mean arterial blood pressure |
control condition |
Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. |
arterial blood pressure trait |
male |
127 days-143 days |
21 |
|
serial mean |
99.8 |
mmHg |
2.18 |
10.0 |
vascular indwelling catheter method |
left femoral artery and vein |
4 hrs/day for 3 days |
|
0 |
|
microrenathane catheter; recover for 1 week after surgery |
|
|
11549 |
101 |
MNS/Gib |
diastolic blood pressure |
control condition |
Zagato et al., 2000, Hypertension, 36(5), 734-9 |
arterial blood pressure trait |
not specified |
112 days
| 15 |
|
continuous mean |
96.9 |
mmHg |
2.8 |
10.84 |
vascular indwelling catheter method |
carotid artery |
1 min tracing every 3-4 min for 1 h |
|
0 |
|
Gould BS3200 BP recorder |
|
|
11724 |
122 |
MHS/Gib |
diastolic blood pressure |
control condition |
Zagato et al., 2000, Hypertension, 36(5), 734-9 |
arterial blood pressure trait |
not specified |
112 days
| 22 |
|
continuous mean |
113.4 |
mmHg |
5.3 |
24.86 |
vascular indwelling catheter method |
carotid artery |
1 min tracing every 3-4 min for 1 h |
|
0 |
|
Gould BS3200 BP recorder |
|
|
11727 |
122 |
WKHA/Cfd |
time constant of left ventricular pressure decay |
sham surgical control condition |
Souzeau E, et al., Hypertension. 2006 Jan;47(1):128-33. Epub 2005 Dec 12. |
heart left ventricular blood pressure trait |
male |
84 days-154 days |
5 |
|
|
13.3 |
ms |
0.27 |
0.6 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
68916 |
1014 |
Crl:WI |
heart rate |
controlled NG-nitroarginine methyl ester content drinking water (20 mg/kg/d) (between 0 and 672 hours) |
Blanc J, et al., J Hypertens. 1999 Nov;17(11):1527-34. |
heart pumping trait |
male |
0 days
| 15 |
|
|
378.0 |
beats/min |
7.0 |
27.11 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
70419 |
1418 |
WKY.WKHA-(D5Rat45-D5Rat245)/Cfd |
left ventricular end-systolic blood pressure |
artificial aortocaval fistula |
Souzeau E, et al., Hypertension. 2006 Jan;47(1):128-33. Epub 2005 Dec 12. |
heart left ventricular blood pressure trait |
female |
84 days-154 days |
5 |
|
|
128.6 |
mmHg |
2.9 |
6.48 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
68873 |
1014 |
BN.GH-(D6Mit12-D6Rat15)/Mcwi |
change in mean arterial blood pressure to change in vasoactive chemical dose ratio |
angiotensin II (5-50 ng/kg/min) (between 0.2 and 1 hours) |
Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. |
arterial blood pressure trait |
male |
130 days-144 days |
11 |
|
|
0.86 |
mmHg/ng/kg/min |
0.02 |
0.08 |
vascular indwelling catheter method |
left femoral artery and vein |
0.0 |
|
0 |
|
microrenathane catheter; recover for 1 week after surgery |
slope of map response curve |
|
68341 |
101 |
WKHA/Cfd |
time constant of left ventricular pressure decay |
artificial aortocaval fistula |
Souzeau E, et al., Hypertension. 2006 Jan;47(1):128-33. Epub 2005 Dec 12. |
heart left ventricular blood pressure trait |
female |
84 days-154 days |
5 |
|
|
21.7 |
ms |
1.6 |
3.58 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
68923 |
1014 |
WKY/Izm |
heart rate |
control condition |
Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. |
heart pumping trait |
male |
98 days
| 6 |
|
|
320.0 |
beats/min |
11.0 |
26.94 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
84550 |
1120 |
SD-Trpv1em1Sage+/+ |
heart rate |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion then dihydrocapsaicin (0.3 mg/kg) (for 0.7 hours) and Capsazepine (3 mg/kg) (for 0.7 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
heart pumping trait |
male |
56 days-70 days |
6 |
|
|
370.0 |
beats/min |
11.0 |
26.94 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
104671 |
2988 |
SD-Trpv1em1Sage+/+ |
heart rate |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion (for 0.2 hours) then dihydrocapsaicin (1 mg/kg) (for 0.9 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
heart pumping trait |
male |
56 days-70 days |
6 |
|
|
385.0 |
beats/min |
15.0 |
36.74 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
104696 |
2988 |
SD-Trpv1em1Sage+/+ |
heart rate |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion (for 0.2 hours) then dihydrocapsaicin (0.3 mg/kg) (for 0.9 hours) and Capsazepine (3 mg/kg) (for 0.9 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
heart pumping trait |
male |
56 days-70 days |
6 |
|
|
385.0 |
beats/min |
10.0 |
24.49 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
104698 |
2988 |
SD-Trpv1em1Sage+/+ |
mean arterial blood pressure |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion (for 0.2 hours) then dihydrocapsaicin (0.3 mg/kg) (for 0.9 hours) and cyclosporine A (2.5 mg/kg) (for 0.9 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
arterial blood pressure trait |
male |
56 days-70 days |
6 |
|
|
88.0 |
mmHg |
5.0 |
12.25 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
104717 |
2988 |
SD-Trpv1em1Sage+/+ |
mean arterial blood pressure |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion (for 0.5 hours) then dihydrocapsaicin (0.3 mg/kg) (for 3.2 hours) and Capsazepine (3 mg/kg) (for 3.2 hours) then Myocardial reperfusion (for 2 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
arterial blood pressure trait |
male |
56 days-70 days |
6 |
|
|
74.0 |
mmHg |
3.0 |
7.35 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
104725 |
2988 |
MW |
mean arterial blood pressure |
nephrectomy (for 28 days) then enalapril (50 mg/l) (for 21 days) |
Anderson S, et al., J Clin Invest. 1986 Jun;77(6):1993-2000. |
arterial blood pressure trait |
male |
0 days
| 8 |
undefined |
|
107.0 |
mmHg |
2.0 |
5.66 |
vascular indwelling catheter method |
|
0.0 |
5/6 nephrectomy |
28 |
days |
|
|
|
100996 |
2561 |
SR/Hsd |
heart rate |
aldosterone (22.5 ng/hr) (for 14 days) and artificial cerebrospinal fluid with 0.15 M sodium (4.4-4.6 ul/hr) (for 14 days) |
Huang BS, et al., Am J Physiol Heart Circ Physiol. 2005 Feb;288(2):H517-24. doi: 10.1152/ajpheart.00651.2004. Epub 2004 Sep 30. |
heart pumping trait |
male |
49 days-57 days |
0 |
|
|
451.0 |
beats/min |
12.0 |
|
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
138375 |
2801 |
WKY.SHRSP-(D1Wox29-D1Arb21)/Izm |
absolute change in mean arterial blood pressure |
vehicle control condition (2 ul) (for 0 hours) then air-jet exposure (for 0 hours) then angiotensin II (20 ng) |
Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. |
arterial blood pressure trait |
male |
98 days
| 6 |
|
|
32.0 |
mmHg |
2.0 |
4.9 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
84568 |
1120 |
WKY/Izm |
absolute change in mean arterial blood pressure |
vehicle control condition (2 ul) (for 0 hours) then air-jet exposure (for 0 hours) then angiotensin II (20 ng) then phenylephrine (3 ug) |
Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. |
arterial blood pressure trait |
male |
98 days
| 6 |
|
|
50.0 |
mmHg |
2.0 |
4.9 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
84570 |
1120 |
WKY/Izm |
mean arterial blood pressure |
control condition |
Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. |
arterial blood pressure trait |
male |
98 days
| 6 |
|
|
106.0 |
mmHg |
3.0 |
7.35 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
84546 |
1120 |
WKY.SHRSP-(D1Wox29-D1Arb21)/Izm |
absolute change in mean arterial blood pressure |
air-jet exposure (for 0 hours) |
Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. |
arterial blood pressure trait |
male |
98 days
| 6 |
|
|
36.0 |
mmHg |
2.0 |
4.9 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
84557 |
1120 |
SS/JrHsdMcwi |
systolic blood pressure |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
92 days-94 days |
12 |
|
serial mean |
160.0 |
mmHg |
6.0 |
20.78 |
vascular indwelling catheter method |
left femoral artery |
0 |
|
0 |
|
|
|
|
65463 |
151 |
BN/NHsdMcwi |
heart rate |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
heart pumping trait |
female |
93 days
| 14 |
|
serial mean |
395.0 |
beats/min |
7.0 |
26.19 |
vascular indwelling catheter method |
left femoral artery |
0 |
|
0 |
|
|
|
|
65468 |
151 |
HTG |
mean arterial blood pressure |
losartan (10 mg/kg) (for 0.2 hours) |
Ueno T, et al., J Mol Med 2003 Jan;81(1):51-60. Epub 2002 Nov 21. |
arterial blood pressure trait |
both |
151 days-181 days |
19 |
|
continuous mean |
115.0 |
mmHg |
3.0 |
13.08 |
vascular indwelling catheter method |
carotid artery, jugular vein |
1800 |
|
0 |
|
|
|
|
64702 |
249 |
WKY.SHR-(D1Rat56-D1M7Mit206)/Njs |
diastolic blood pressure |
control condition |
Frantz S, et al., Hypertension 2001 Aug;38(2):216-21 |
arterial blood pressure trait |
male |
196 days
| 15 |
|
|
107.9 |
mmHg |
2.69 |
10.4 |
vascular indwelling catheter method |
|
|
|
0 |
|
beat to beat for 1 hour |
|
|
11334 |
72 |
SHR.WKY-(D1Wox19-D1Wox34)/Njs |
diastolic blood pressure |
control condition |
Frantz S, et al., Hypertension 2001 Aug;38(2):216-21 |
arterial blood pressure trait |
male |
196 days
| 20 |
|
|
137.3 |
mmHg |
2.33 |
10.4 |
vascular indwelling catheter method |
|
|
|
0 |
|
beat to beat for 1 hour |
|
|
11337 |
72 |
BN.GH-(D2Rat22-D2Mgh11)/Mcwi |
mean arterial blood pressure |
control condition |
Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. |
arterial blood pressure trait |
male |
127 days-143 days |
19 |
|
serial mean |
103.8 |
mmHg |
2.11 |
9.2 |
vascular indwelling catheter method |
left femoral artery and vein |
4 hrs/day for 3 days |
|
0 |
|
microrenathane catheter; recover for 1 week after surgery |
|
|
11528 |
101 |
BN/NHsdMcwi |
absolute change in mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then angiotensin II (200 ng/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101 days-103 days |
20 |
|
serial mean |
27.0 |
mmHg |
2.0 |
8.94 |
vascular indwelling catheter method |
left femoral artery |
0.0 |
|
0 |
|
|
|
|
67299 |
151 |
F344/NHsd |
mean pulmonary arterial blood pressure |
air oxygen content (10 %) (for 21 days) |
Zhao L et al., 2001, Circulation, 103(3), 442-7 |
pulmonary arterial blood pressure trait |
male |
105 days
| 23 |
|
median |
27.0 |
mmHg |
|
|
vascular indwelling catheter method |
pulmonary artery |
0 |
|
0 |
|
|
|
|
11566 |
102 |
SHR/Izm |
mean arterial blood pressure |
control condition |
Tsujita Y, et al., Am J Physiol Heart Circ Physiol 2000 Nov;279(5):H2062-7 |
arterial blood pressure trait |
male |
168 days
| 6 |
|
continuous mean |
174.0 |
mmHg |
2.86 |
7.0 |
vascular indwelling catheter method |
|
30 min between 2-5 pm |
|
0 |
|
polyethylene catheter (PE-50) |
|
|
11581 |
103 |
LN/Mav |
systolic blood pressure |
control condition |
Dubay C, et al., Nat Genet 1993 Apr;3(4):354-7 |
arterial blood pressure trait |
male |
203 days-217 days |
14 |
|
serial mean |
136.4 |
mmHg |
|
|
vascular indwelling catheter method |
abdominal aorta |
10800 |
|
0 |
|
|
|
|
11646 |
111 |
SHRSP/Bbb |
heart rate |
control condition |
Kreutz R, et al., Circulation 1997 Aug 19;96(4):1078-81. |
heart pumping trait |
male |
112 days
| 12 |
|
serial mean |
394.0 |
beats/min |
7.22 |
25.0 |
vascular indwelling catheter method |
femoral artery |
|
|
0 |
|
|
3 sets of readings per day for two days |
|
13288 |
334 |
LN/MavRrrc |
absolute change in systolic blood pressure |
trimethaphan camsylate (10 mg/kg) (for 0.2 hours) |
Vincent M, et al., J Clin Invest 1997 Oct 15;100(8):2000-6 |
arterial blood pressure trait |
not specified |
203 days-217 days |
15 |
|
serial mean |
-56.5 |
mmHg |
2.01 |
7.8 |
vascular indwelling catheter method |
abdominal aorta |
3600 |
|
0 |
|
|
|
|
65263 |
121 |
SHR |
systolic blood pressure |
control condition |
Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6. |
arterial blood pressure trait |
male |
99 days
| 23 |
|
continuous mean |
188.0 |
mmHg |
2.0 |
9.59 |
vascular indwelling catheter method |
femoral artery |
1800 |
|
0 |
|
pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH) |
|
|
65347 |
306 |
SHR.BN-(D2Rat114-D2Rat123)/Jk |
diastolic blood pressure |
control condition |
Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6. |
arterial blood pressure trait |
male |
99 days
| 22 |
|
continuous mean |
127.0 |
mmHg |
2.0 |
9.38 |
vascular indwelling catheter method |
femoral artery |
1800 |
|
0 |
|
pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH) |
|
|
65352 |
306 |
SHR |
heart rate |
control condition (for 98 days) |
Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6. |
heart pumping trait |
male |
87 days
| 23 |
|
continuous mean |
365.0 |
beats/min |
3.0 |
14.39 |
vascular indwelling catheter method |
femoral artery |
1800 |
|
0 |
|
pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH) |
|
|
65353 |
306 |
SHR.BN-(D16Rat87-D16Mgh1)/Jk |
systolic blood pressure |
controlled sodium content drinking water (1 %) (for 15 days) |
Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6. |
arterial blood pressure trait |
male |
99 days
| 23 |
|
continuous mean |
178.5 |
mmHg |
2.7 |
12.95 |
vascular indwelling catheter method |
femoral artery |
1800 |
|
0 |
|
pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH) |
|
|
12753 |
306 |
WKY |
diastolic blood pressure |
control condition |
Frantz SA, et al., Hypertension 1998 Oct;32(4):639-46 |
arterial blood pressure trait |
male |
175 days
| 24 |
|
continuous mean |
102.1 |
mmHg |
2.47 |
12.1 |
vascular indwelling catheter method |
aorta |
|
|
0 |
|
|
|
|
11902 |
206 |
SHR |
systolic blood pressure |
control condition |
Frantz SA, et al., Hypertension 1998 Oct;32(4):639-46 |
arterial blood pressure trait |
male |
175 days
| 28 |
|
continuous mean |
232.2 |
mmHg |
2.29 |
12.1 |
vascular indwelling catheter method |
aorta |
|
|
0 |
|
|
|
|
11903 |
206 |
WKY/Gcrc |
systolic blood pressure |
control condition |
Graham D, et al., Hypertension. 2007 Dec; 50(6):1134-41. |
arterial blood pressure trait |
male |
91 days-126 days |
10 |
|
|
137.4 |
mmHg |
2.17 |
6.86 |
vascular indwelling catheter method |
abdominal aorta |
3024000 |
|
0 |
|
implanted at 84 days with 7 day recovery; Dataquest IV telemetry system (Data Sciences International) |
|
|
12726 |
302 |
LEW |
diastolic blood pressure |
control condition |
Ueno T, et al., Physiol Genomics 2004 Mar 12;17(1):38-47. |
arterial blood pressure trait |
male |
151 days-181 days |
9 |
|
|
80.3 |
mmHg |
2.9 |
8.7 |
vascular indwelling catheter method |
carotid artery and jugular vein |
|
|
0 |
|
polyethylene catheter |
|
|
11716 |
120 |
GH/Omr |
diastolic blood pressure |
control condition |
Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. |
arterial blood pressure trait |
male |
127 days-143 days |
21 |
|
serial mean |
129.5 |
mmHg |
3.27 |
15.0 |
vascular indwelling catheter method |
left femoral artery and vein |
4 hrs/day for 3 days |
|
0 |
|
microrenathane catheter; recover for 1 week after surgery |
|
|
11523 |
101 |
LEW/CrlCrlj |
mean arterial blood pressure |
control condition |
Tsujita Y, et al., Am J Physiol Heart Circ Physiol 2000 Nov;279(5):H2062-7 |
arterial blood pressure trait |
male |
168 days
| 5 |
|
continuous mean |
112.0 |
mmHg |
1.34 |
3.0 |
vascular indwelling catheter method |
|
30 min between 2-5 pm |
|
0 |
|
polyethylene catheter (PE-50) |
|
|
11580 |
103 |
HTG |
diastolic blood pressure |
control condition |
Ueno T, et al., Physiol Genomics 2004 Mar 12;17(1):38-47. |
arterial blood pressure trait |
male |
151 days-181 days |
10 |
|
|
103.2 |
mmHg |
3.2 |
10.12 |
vascular indwelling catheter method |
carotid artery and jugular vein |
|
|
0 |
|
polyethylene catheter |
|
|
11712 |
120 |
BN/NHsdMcwi |
systolic blood pressure |
controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (between 22 and 24 days) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
89 days-92 days |
21 |
|
serial mean |
130.0 |
mmHg |
4.0 |
18.33 |
vascular indwelling catheter method |
left femoral artery |
|
|
0 |
|
3 hrs (during inactive phase) 3 consecutive days, and 4 extra hrs (during active phase) next day |
|
|
11849 |
151 |
SS/JrHsdMcwi |
mean arterial blood pressure |
controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (between 22 and 24 days) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
89 days-92 days |
21 |
|
serial mean |
174.0 |
mmHg |
6.0 |
27.5 |
vascular indwelling catheter method |
left femoral artery |
|
|
0 |
|
3 hrs (during inactive phase) 3 consecutive days, and 4 extra hrs (during active phase) next day |
|
|
11854 |
151 |
SS/JrHsdMcwi |
diastolic blood pressure |
controlled sodium content diet (0.1 %) (for 28 days) then controlled sodium content diet (8 %) (for 31 days) and controlled exposure to ambient light (for 12 hours) |
Cowley AW Jr, et al., Physiol Genomics 2000 Apr 27;2(3):107-15. |
arterial blood pressure trait |
male |
91 days-94 days |
35 |
|
continuous mean |
167.0 |
mmHg |
4.0 |
23.66 |
vascular indwelling catheter method |
femoral artery |
259200.0 |
|
0 |
|
3 h per day |
|
|
12002 |
229 |
LEW/Cub |
systolic blood pressure |
losartan (10 mg/kg) (for 0.2 hours) then pentolinium (5 mg/kg) (for 0.1 hours) then NG-nitroarginine methyl ester (30 mg/kg) (for 0.3 hours) |
Ueno T, et al., Physiol Res 2003;52(6):689-700. |
arterial blood pressure trait |
not specified |
0 days
| 9 |
|
continuous mean |
128.5 |
mmHg |
|
|
vascular indwelling catheter method |
|
|
|
0 |
|
|
|
|
65383 |
568 |
SHR.BN-(D2Rat226-D2Rat294)/Jk |
systolic blood pressure |
control condition |
Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6. |
arterial blood pressure trait |
male |
99 days
| 22 |
|
continuous mean |
168.0 |
mmHg |
2.0 |
9.38 |
vascular indwelling catheter method |
femoral artery |
1800 |
|
0 |
|
pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH) |
|
|
65400 |
306 |
SHR.BN-(D2Rat226-D2Rat294)/Jk |
heart rate |
control condition (for 98 days) |
Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6. |
heart pumping trait |
male |
87 days
| 22 |
|
continuous mean |
340.0 |
beats/min |
5.0 |
23.45 |
vascular indwelling catheter method |
femoral artery |
1800 |
|
0 |
|
pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH) |
|
|
65422 |
306 |
LN/MavRrrc |
absolute change in systolic blood pressure |
losartan (20 mg/kg) (for 0.7 hours) |
Vincent M, et al., J Clin Invest 1997 Oct 15;100(8):2000-6 |
arterial blood pressure trait |
not specified |
203 days-217 days |
15 |
|
serial mean |
-0.8 |
mmHg |
1.32 |
5.13 |
vascular indwelling catheter method |
abdominal aorta |
3600 |
|
0 |
|
|
|
|
65259 |
121 |
BN-Lx/Cub |
mean arterial blood pressure |
control condition |
Pravenec M, et al., J Hypertens 1989 Mar;7(3):217-21. |
arterial blood pressure trait |
male |
0 days
| 8 |
|
|
113.0 |
mmHg |
3.0 |
16.16 |
vascular indwelling catheter method |
carotid artery segment |
0.0 |
|
0 |
|
|
|
|
66038 |
651 |
SHR/Ola |
mean arterial blood pressure |
control condition |
Pravenec M, et al., J Hypertens 1989 Mar;7(3):217-21. |
arterial blood pressure trait |
male |
0 days
| 29 |
|
|
181.0 |
mmHg |
4.0 |
11.31 |
vascular indwelling catheter method |
carotid artery segment |
0.0 |
|
0 |
|
|
|
|
66039 |
651 |
F344/NHsd |
mean arterial blood pressure |
air oxygen content (10 %) (for 21 days) |
Zhao L et al., 2001, Circulation, 103(3), 442-7 |
arterial blood pressure trait |
male |
105 days
| 23 |
|
median |
112.0 |
mmHg |
|
|
vascular indwelling catheter method |
left common carotid artery |
0 |
|
0 |
|
|
|
|
66128 |
102 |
WKY/Cfd |
left ventricular end-diastolic blood pressure |
artificial aortocaval fistula |
Souzeau E, et al., Hypertension. 2006 Jan;47(1):128-33. Epub 2005 Dec 12. |
heart left ventricular blood pressure trait |
female |
84 days-154 days |
5 |
|
|
1.34 |
mmHg |
0.7 |
1.57 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
68809 |
1014 |
BN/NHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then norepinephrine (0.5 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101 days-103 days |
21 |
|
serial mean |
120.4 |
mmHg |
5.3 |
24.29 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
0 |
|
|
|
|
69535 |
151 |
BN/NHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then norepinephrine (1 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101 days-103 days |
21 |
|
serial mean |
128.6 |
mmHg |
4.0 |
18.33 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
0 |
|
|
|
|
69537 |
151 |
BN/NHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then norepinephrine (3 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101 days-103 days |
20 |
|
serial mean |
135.6 |
mmHg |
3.2 |
14.31 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
0 |
|
|
|
|
69539 |
151 |
SS/JrHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then acetylcholine (0.1 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101 days-103 days |
9 |
|
serial mean |
132.0 |
mmHg |
7.0 |
21.0 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
0 |
|
|
|
|
69542 |
151 |
BN/NHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then acetylcholine (0.2 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101 days-103 days |
16 |
|
serial mean |
118.6 |
mmHg |
3.4 |
13.6 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
0 |
|
|
|
|
69543 |
151 |
SS/JrHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then NG-nitroarginine methyl ester (5 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101 days-103 days |
9 |
|
serial mean |
159.0 |
mmHg |
7.1 |
21.3 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
0 |
|
|
|
|
69546 |
151 |
BN/NHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then NG-nitroarginine methyl ester (5 mg/kg) then acetylcholine (0.1 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101 days-103 days |
21 |
|
serial mean |
138.6 |
mmHg |
3.8 |
17.41 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
0 |
|
|
|
|
69547 |
151 |
BN/NHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then NG-nitroarginine methyl ester (5 mg/kg) then acetylcholine (0.2 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101 days-103 days |
17 |
|
serial mean |
144.9 |
mmHg |
3.1 |
12.78 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
0 |
|
|
|
|
69549 |
151 |
WKY.WKHA-(D5Rat45-D5Rat245)/Cfd |
time constant of left ventricular pressure decay |
artificial aortocaval fistula |
Souzeau E, et al., Hypertension. 2006 Jan;47(1):128-33. Epub 2005 Dec 12. |
heart left ventricular blood pressure trait |
male |
84 days-154 days |
5 |
|
|
13.2 |
ms |
1.8 |
4.02 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
68919 |
1014 |
WKY/Cfd |
time constant of left ventricular pressure decay |
artificial aortocaval fistula |
Souzeau E, et al., Hypertension. 2006 Jan;47(1):128-33. Epub 2005 Dec 12. |
heart left ventricular blood pressure trait |
female |
84 days-154 days |
5 |
|
|
13.36 |
ms |
1.4 |
3.13 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
68921 |
1014 |
WKHA/Cfd |
time constant of left ventricular pressure decay |
sham surgical control condition |
Souzeau E, et al., Hypertension. 2006 Jan;47(1):128-33. Epub 2005 Dec 12. |
heart left ventricular blood pressure trait |
female |
84 days-154 days |
5 |
|
|
13.5 |
ms |
1.8 |
4.02 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
68922 |
1014 |
Crl:WI |
systolic blood pressure |
control condition |
Blanc J, et al., J Hypertens. 1999 Nov;17(11):1527-34. |
arterial blood pressure trait |
male |
0 days
| 13 |
|
|
132.0 |
mmHg |
4.0 |
14.42 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
70415 |
1418 |
WKY/Cfd |
maximum rate of positive change in left ventricular blood pressure |
sham surgical control condition |
Souzeau E, et al., Hypertension. 2006 Jan;47(1):128-33. Epub 2005 Dec 12. |
heart left ventricular blood pressure trait |
male |
84 days-154 days |
5 |
|
|
9876.0 |
mmHg/s |
495.0 |
1106.85 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
"rate of maximum positive change in left ventricular blood pressure" mmHg/s |
|
68890 |
1014 |
BN/NHsdMcwi |
systolic blood pressure |
controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (between 22 and 24 days) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
94 days
| 17 |
|
serial mean |
134.6 |
mmHg |
4.1 |
16.9 |
vascular indwelling catheter method |
left femoral artery |
10800.0 |
|
0 |
|
|
|
|
69521 |
151 |
BN/NHsdMcwi |
diastolic blood pressure |
controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (between 22 and 24 days) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
94 days
| 17 |
|
serial mean |
91.6 |
mmHg |
3.6 |
14.84 |
vascular indwelling catheter method |
left femoral artery |
10800.0 |
|
0 |
|
|
|
|
69523 |
151 |
BN/NHsdMcwi |
heart rate |
controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (between 22 and 24 days) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
heart pumping trait |
female |
94 days
| 16 |
|
serial mean |
370.1 |
beats/min |
6.3 |
25.2 |
vascular indwelling catheter method |
left femoral artery |
10800.0 |
|
0 |
|
|
|
|
69525 |
151 |
Crl:WI |
heart rate |
control condition |
Blanc J, et al., J Hypertens. 1999 Nov;17(11):1527-34. |
heart pumping trait |
male |
0 days
| 13 |
|
|
363.0 |
beats/min |
8.0 |
28.84 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
70420 |
1418 |
WKY.WKHA-(D5Rat45-D5Rat245)/Cfd |
left ventricular end-diastolic blood pressure |
artificial aortocaval fistula |
Souzeau E, et al., Hypertension. 2006 Jan;47(1):128-33. Epub 2005 Dec 12. |
heart left ventricular blood pressure trait |
female |
84 days-154 days |
5 |
|
|
0.33 |
mmHg |
0.18 |
0.4 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
68860 |
1014 |
WKHA/Cfd |
left ventricular end-diastolic blood pressure |
sham surgical control condition |
Souzeau E, et al., Hypertension. 2006 Jan;47(1):128-33. Epub 2005 Dec 12. |
heart left ventricular blood pressure trait |
female |
84 days-154 days |
5 |
|
|
1.99 |
mmHg |
0.42 |
0.94 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
68857 |
1014 |
WKY.WKHA-(D5Rat45-D5Rat245)/Cfd |
left ventricular end-systolic blood pressure |
sham surgical control condition |
Souzeau E, et al., Hypertension. 2006 Jan;47(1):128-33. Epub 2005 Dec 12. |
heart left ventricular blood pressure trait |
male |
84 days-154 days |
5 |
|
|
139.9 |
mmHg |
4.8 |
10.73 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
68865 |
1014 |
WKY/Cfd |
left ventricular end-systolic blood pressure |
artificial aortocaval fistula |
Souzeau E, et al., Hypertension. 2006 Jan;47(1):128-33. Epub 2005 Dec 12. |
heart left ventricular blood pressure trait |
female |
84 days-154 days |
5 |
|
|
119.6 |
mmHg |
3.6 |
8.05 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
68868 |
1014 |
WKHA/Cfd |
left ventricular end-systolic blood pressure |
artificial aortocaval fistula |
Souzeau E, et al., Hypertension. 2006 Jan;47(1):128-33. Epub 2005 Dec 12. |
heart left ventricular blood pressure trait |
female |
84 days-154 days |
5 |
|
|
130.0 |
mmHg |
5.5 |
12.3 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
68870 |
1014 |
WKHA/Cfd |
maximum rate of positive change in left ventricular blood pressure |
sham surgical control condition |
Souzeau E, et al., Hypertension. 2006 Jan;47(1):128-33. Epub 2005 Dec 12. |
heart left ventricular blood pressure trait |
male |
84 days-154 days |
5 |
|
|
9127.0 |
mmHg/s |
286.0 |
639.52 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
68892 |
1014 |
WKY.WKHA-(D5Rat45-D5Rat245)/Cfd |
maximum rate of positive change in left ventricular blood pressure |
sham surgical control condition |
Souzeau E, et al., Hypertension. 2006 Jan;47(1):128-33. Epub 2005 Dec 12. |
heart left ventricular blood pressure trait |
male |
84 days-154 days |
5 |
|
|
10888.0 |
mmHg/s |
484.0 |
1082.26 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
68894 |
1014 |
WKY/Cfd |
maximum rate of negative change in left ventricular blood pressure |
artificial aortocaval fistula |
Souzeau E, et al., Hypertension. 2006 Jan;47(1):128-33. Epub 2005 Dec 12. |
heart left ventricular blood pressure trait |
male |
84 days-154 days |
5 |
|
|
6595.0 |
mmHg/s |
297.0 |
664.11 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
68903 |
1014 |
WKY/Cfd |
maximum rate of negative change in left ventricular blood pressure |
artificial aortocaval fistula |
Souzeau E, et al., Hypertension. 2006 Jan;47(1):128-33. Epub 2005 Dec 12. |
heart left ventricular blood pressure trait |
female |
84 days-154 days |
5 |
|
|
6670.0 |
mmHg/s |
179.0 |
400.26 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
68909 |
1014 |
WKY.WKHA-(D5Rat45-D5Rat245)/Cfd |
maximum rate of negative change in left ventricular blood pressure |
sham surgical control condition |
Souzeau E, et al., Hypertension. 2006 Jan;47(1):128-33. Epub 2005 Dec 12. |
heart left ventricular blood pressure trait |
female |
84 days-154 days |
5 |
|
|
6589.0 |
mmHg/s |
296.0 |
661.88 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
68912 |
1014 |
WKY/NCrl |
diastolic blood pressure |
controlled sodium content diet (8 %) (for 14 days) then controlled exposure to ambient light (for 14 days) |
Iwai N, et al., Circulation 1999 Nov 2;100(18):1923-9. |
arterial blood pressure trait |
male |
126 days
| 7 |
|
|
89.3 |
mmHg |
0.76 |
2.0 |
vascular indwelling catheter method |
left common carotid artery |
0.0 |
|
0 |
|
|
daytime (7 AM - 7 PM) |
|
70087 |
1281 |
BN/NHsdMcwi |
systolic blood pressure |
controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (between 22 and 24 days) then controlled exposure to darkness (for 12 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
89 days-91 days |
20 |
|
serial mean |
130.0 |
mmHg |
3.5 |
15.65 |
vascular indwelling catheter method |
left femoral artery |
0.0 |
|
0 |
|
|
|
|
69443 |
151 |
SS/JrHsdMcwi |
systolic blood pressure |
controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (between 22 and 24 days) then controlled exposure to darkness (for 12 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
89 days-91 days |
15 |
|
serial mean |
184.0 |
mmHg |
7.7 |
29.82 |
vascular indwelling catheter method |
left femoral artery |
0.0 |
|
0 |
|
|
|
|
69444 |
151 |
SS/JrHsdMcwi |
diastolic blood pressure |
controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (between 22 and 24 days) then controlled exposure to darkness (for 12 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
89 days-91 days |
15 |
|
serial mean |
139.0 |
mmHg |
6.0 |
23.24 |
vascular indwelling catheter method |
left femoral artery |
0.0 |
|
0 |
|
|
|
|
69446 |
151 |
BN/NHsdMcwi |
heart rate |
controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (between 22 and 24 days) then controlled exposure to darkness (for 12 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
heart pumping trait |
female |
89 days-91 days |
18 |
|
serial mean |
386.0 |
beats/min |
4.1 |
17.39 |
vascular indwelling catheter method |
left femoral artery |
0.0 |
|
0 |
|
|
|
|
69449 |
151 |
FHH/EurMcwi |
mean arterial blood pressure |
control condition |
O'Meara CC, et al., Physiol Genomics. 2012 Aug 1;44(15):741-53. doi: 10.1152/physiolgenomics.00187.2011. Epub 2012 Jun 5. |
arterial blood pressure trait |
male |
189 days
| 7 |
|
serial mean |
123.0 |
mmHg |
8.0 |
21.17 |
vascular indwelling catheter method |
femoral artery |
10800.0 |
|
0 |
|
1day/week |
|
|
96903 |
1738 |
WKY.SHRSP-(D1Wox29-D1Arb21)/Izm |
absolute change in mean arterial blood pressure |
candesartan (1 ug) (for 0 hours) then air-jet exposure (for 0 hours) then angiotensin II (20 ng) |
Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. |
arterial blood pressure trait |
male |
98 days
| 6 |
|
|
-1.0 |
mmHg |
4.0 |
9.8 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
84569 |
1120 |
WKY.SHRSP-(D1Wox29-D1Arb21)/Izm |
absolute change in mean arterial blood pressure |
candesartan (1 ug) (for 0 hours) then air-jet exposure (for 0 hours) then angiotensin II (20 ng) then phenylephrine (3 ug) |
Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. |
arterial blood pressure trait |
male |
98 days
| 6 |
|
|
56.0 |
mmHg |
2.0 |
4.9 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
84573 |
1120 |
MW |
mean arterial blood pressure |
doxorubicin (2 mg/kg) |
Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. |
arterial blood pressure trait |
male |
0 days
| 7 |
undefined |
|
117.0 |
mmHg |
4.0 |
10.58 |
vascular indwelling catheter method |
|
0.0 |
doxorubicin |
29 |
days |
|
|
|
101175 |
2581 |
SD-Trpv1em1Sage+/+ |
mean arterial blood pressure |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion then dihydrocapsaicin (0.1 mg/kg) (for 0.7 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
arterial blood pressure trait |
male |
56 days-70 days |
6 |
|
|
128.0 |
mmHg |
4.0 |
9.8 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
104676 |
2988 |
SD-Trpv1em1Sage+/+ |
mean arterial blood pressure |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion then dihydrocapsaicin (0.3 mg/kg) (for 0.7 hours) and Capsazepine (3 mg/kg) (for 0.7 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
arterial blood pressure trait |
male |
56 days-70 days |
6 |
|
|
134.0 |
mmHg |
4.0 |
9.8 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
104680 |
2988 |
SD-Trpv1em1Sage+/+ |
mean arterial blood pressure |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion then dihydrocapsaicin (0.3 mg/kg) (for 0.7 hours) and cyclosporine A (2.5 mg/kg) (for 0.7 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
arterial blood pressure trait |
male |
56 days-70 days |
6 |
|
|
100.0 |
mmHg |
4.0 |
9.8 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
104681 |
2988 |
SD-Trpv1em1Sage+/+ |
mean arterial blood pressure |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion then cyclosporine A (2.5 mg/kg) (for 0.7 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
arterial blood pressure trait |
male |
56 days-70 days |
6 |
|
|
106.0 |
mmHg |
5.0 |
12.25 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
104683 |
2988 |
SD-Trpv1em1Sage+/+ |
heart rate |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion (for 0.2 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
heart pumping trait |
male |
56 days-70 days |
6 |
|
|
352.0 |
beats/min |
4.0 |
9.8 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
104693 |
2988 |
SD-Trpv1em1Sage+/+ |
heart rate |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion (for 0.2 hours) then dihydrocapsaicin (0.3 mg/kg) (for 0.9 hours) and cyclosporine A (2.5 mg/kg) (for 0.9 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
heart pumping trait |
male |
56 days-70 days |
6 |
|
|
443.0 |
beats/min |
5.0 |
12.25 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
104699 |
2988 |
SD-Trpv1em1Sage+/+ |
heart rate |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion (for 0.2 hours) then Capsazepine (3 mg/kg) (for 0.9 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
heart pumping trait |
male |
56 days-70 days |
5 |
|
|
356.0 |
beats/min |
14.0 |
31.3 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
104700 |
2988 |
SD-Trpv1em1Sage+/+ |
heart rate |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion (for 0.5 hours) then dihydrocapsaicin (0.1 mg/kg) (for 3.2 hours) then Myocardial reperfusion (for 2 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
heart pumping trait |
male |
56 days-70 days |
6 |
|
|
362.0 |
beats/min |
6.0 |
14.7 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
104703 |
2988 |
SD-Trpv1em1Sage+/+ |
mean arterial blood pressure |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion (for 0.2 hours) then dihydrocapsaicin (0.3 mg/kg) (for 0.9 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
arterial blood pressure trait |
male |
56 days-70 days |
6 |
|
|
89.0 |
mmHg |
14.0 |
34.29 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
104713 |
2988 |
SD-Trpv1em1Sage+/+ |
mean arterial blood pressure |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion (for 0.2 hours) then dihydrocapsaicin (3 mg/kg) (for 0.9 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
arterial blood pressure trait |
male |
56 days-70 days |
6 |
|
|
113.0 |
mmHg |
5.0 |
12.25 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
104715 |
2988 |
SD-Trpv1em1Sage+/+ |
mean arterial blood pressure |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion (for 0.5 hours) then dihydrocapsaicin (0.1 mg/kg) (for 3.2 hours) then Myocardial reperfusion (for 2 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
arterial blood pressure trait |
male |
56 days-70 days |
6 |
|
|
86.0 |
mmHg |
5.0 |
12.25 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
104721 |
2988 |
SD-Trpv1em1Sage+/+ |
heart rate |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion then cyclosporine A (2.5 mg/kg) (for 0.7 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
heart pumping trait |
male |
56 days-70 days |
6 |
|
|
413.0 |
beats/min |
14.0 |
34.29 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
104750 |
2988 |
SD-Trpv1em1Sage-/- |
heart rate |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
heart pumping trait |
male |
56 days-70 days |
6 |
|
|
423.0 |
beats/min |
14.0 |
34.29 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
104751 |
2988 |
SD-Trpv1em1Sage+/+ |
mean arterial blood pressure |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion then dihydrocapsaicin (0.3 mg/kg) (for 0.7 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
arterial blood pressure trait |
male |
56 days-70 days |
6 |
|
|
134.0 |
mmHg |
3.0 |
7.35 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
104754 |
2988 |
SD-Trpv1em1Sage+/+ |
heart rate |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion (for 0.2 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
heart pumping trait |
male |
56 days-70 days |
6 |
|
|
385.0 |
beats/min |
11.0 |
26.94 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
104771 |
2988 |
SD-Trpv1em1Sage+/+ |
heart rate |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion (for 0.2 hours) then dihydrocapsaicin (0.3 mg/kg) (for 0.9 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
heart pumping trait |
male |
56 days-70 days |
6 |
|
|
377.0 |
beats/min |
11.0 |
26.94 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
104772 |
2988 |
SD-Trpv1em1Sage-/- |
heart rate |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion (for 0.2 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
heart pumping trait |
male |
56 days-70 days |
6 |
|
|
430.0 |
beats/min |
12.0 |
29.39 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
104775 |
2988 |
SD-Trpv1em1Sage+/+ |
mean arterial blood pressure |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion (for 0.2 hours) then dihydrocapsaicin (0.3 mg/kg) (for 0.9 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
arterial blood pressure trait |
male |
56 days-70 days |
6 |
|
|
118.0 |
mmHg |
10.0 |
24.49 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
104778 |
2988 |
SD-Trpv1em1Sage+/+ |
mean arterial blood pressure |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion (for 0.2 hours) then cyclosporine A (2.5 mg/kg) (for 0.9 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
arterial blood pressure trait |
male |
56 days-70 days |
6 |
|
|
75.0 |
mmHg |
6.0 |
14.7 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
104780 |
2988 |
SD-Trpv1em1Sage-/- |
mean arterial blood pressure |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion (for 0.5 hours) then Myocardial reperfusion (for 2 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
arterial blood pressure trait |
male |
56 days-70 days |
6 |
|
|
82.0 |
mmHg |
7.0 |
17.15 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
104805 |
2988 |
SS/NEisSlc |
systolic blood pressure |
controlled cilazapril content drinking water (12.5 ug/ml) (for 547.5 days) |
Hirawa N, et al., Hypertension. 1999 Sep;34(3):496-502. |
arterial blood pressure trait |
not specified |
547 days
| 10 |
|
|
122.0 |
mmHg |
4.0 |
12.65 |
vascular indwelling catheter method |
femoral artery |
0.0 |
|
0 |
|
|
|
|
106789 |
2339 |
SS/NEisSlc |
systolic blood pressure |
vehicle control condition (for 547.5 days) |
Hirawa N, et al., Hypertension. 1999 Sep;34(3):496-502. |
arterial blood pressure trait |
not specified |
547 days
| 10 |
|
|
137.0 |
mmHg |
3.0 |
9.49 |
vascular indwelling catheter method |
femoral artery |
0.0 |
|
0 |
|
|
|
|
106791 |
2339 |
SHRSP/A3NCrl |
mean arterial blood pressure |
control condition |
Costell MH, etal., Front Pharmacol. 2012 Jul 5;3:128. doi: 10.3389/fphar.2012.00128. eCollection 2012. |
arterial blood pressure trait |
male |
82 days-89 days |
9 |
|
serial mean |
142.0 |
mmHg |
4.0 |
12.0 |
vascular indwelling catheter method |
femoral artery |
432000.0 |
|
0 |
|
10 seconds every 5 minutes for 24hr |
baseline standard diet group |
baseline and after treatment |
107045 |
3073 |
SHRSP/A3NCrl |
mean arterial blood pressure |
controlled sodium chloride content drinking water (1 %) and controlled fat content diet (24.5 %) |
Costell MH, etal., Front Pharmacol. 2012 Jul 5;3:128. doi: 10.3389/fphar.2012.00128. eCollection 2012. |
arterial blood pressure trait |
male |
82 days-89 days |
9 |
|
serial mean |
140.0 |
mmHg |
2.0 |
6.0 |
vascular indwelling catheter method |
femoral artery |
432000.0 |
|
0 |
|
10 seconds every 5 minutes for 24hr |
baseline high salt high fat diet group |
baseline and after treatment |
107046 |
3073 |
SHRSP/A3NCrl |
mean arterial blood pressure |
controlled sodium chloride content drinking water (1 %) (for 56 days) and controlled fat content diet (24.5 %) (for 56 days) then controlled BAY60-4552 content diet (3 mg/kg/d) (for 49 days) |
Costell MH, etal., Front Pharmacol. 2012 Jul 5;3:128. doi: 10.3389/fphar.2012.00128. eCollection 2012. |
arterial blood pressure trait |
male |
99 days-141 days |
9 |
|
serial mean |
175.0 |
mmHg |
1.0 |
3.0 |
vascular indwelling catheter method |
femoral artery |
432000.0 |
|
0 |
|
10 seconds every 5 minutes for 24hr |
high salt high fat diet +8 wk treat group |
baseline and after treatment |
107050 |
3073 |
HsdCpb:WU |
mean arterial blood pressure |
sham surgical control condition |
Szymanski MK, etal., Basic Res Cardiol. 2012 Mar;107(2):242. doi: 10.1007/s00395-011-0242-4. Epub 2012 Jan 19. |
arterial blood pressure trait |
male |
84 days
| 5 |
|
|
89.0 |
mmHg |
4.0 |
8.94 |
vascular indwelling catheter method |
aorta |
0.0 |
|
0 |
|
|
|
|
108772 |
3130 |
HsdCpb:WU |
left ventricular systolic blood pressure |
sham surgical control condition |
Szymanski MK, etal., Basic Res Cardiol. 2012 Mar;107(2):242. doi: 10.1007/s00395-011-0242-4. Epub 2012 Jan 19. |
heart left ventricular blood pressure trait |
male |
84 days
| 5 |
|
|
117.0 |
mmHg |
5.0 |
11.18 |
vascular indwelling catheter method |
heart left ventricle |
0.0 |
|
0 |
|
|
|
|
108774 |
3130 |
MWF/Hsd |
maximum rate of negative change in left ventricular blood pressure |
sham surgical control condition |
Szymanski MK, etal., Basic Res Cardiol. 2012 Mar;107(2):242. doi: 10.1007/s00395-011-0242-4. Epub 2012 Jan 19. |
heart left ventricular blood pressure trait |
male |
175 days
| 9 |
|
|
6199.0 |
mmHg/s |
513.0 |
1539.0 |
vascular indwelling catheter method |
heart left ventricle |
0.0 |
|
0 |
|
|
|
|
108856 |
3130 |
MWF/Hsd |
maximum rate of negative change in left ventricular blood pressure |
left anterior descending coronary artery occlusion |
Szymanski MK, etal., Basic Res Cardiol. 2012 Mar;107(2):242. doi: 10.1007/s00395-011-0242-4. Epub 2012 Jan 19. |
heart left ventricular blood pressure trait |
male |
175 days
| 10 |
|
|
4377.0 |
mmHg/s |
299.0 |
945.52 |
vascular indwelling catheter method |
heart left ventricle |
0.0 |
|
0 |
|
|
|
|
108857 |
3130 |
HsdCpb:WU |
renal vascular resistance |
control condition |
Szymanski MK, etal., Basic Res Cardiol. 2012 Mar;107(2):242. doi: 10.1007/s00395-011-0242-4. Epub 2012 Jan 19. |
arterial blood pressure trait |
male |
84 days
| 5 |
|
|
17.0 |
mmHg/ml/min |
4.0 |
8.94 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
108898 |
3130 |
MWF/Hsd |
heart rate |
sham surgical control condition |
Szymanski MK, etal., Basic Res Cardiol. 2012 Mar;107(2):242. doi: 10.1007/s00395-011-0242-4. Epub 2012 Jan 19. |
heart pumping trait |
male |
84 days
| 5 |
|
|
364.0 |
beats/min |
14.0 |
31.3 |
vascular indwelling catheter method |
heart |
0.0 |
|
0 |
|
|
|
|
108779 |
3130 |
MWF/Hsd |
left ventricular systolic blood pressure |
sham surgical control condition |
Szymanski MK, etal., Basic Res Cardiol. 2012 Mar;107(2):242. doi: 10.1007/s00395-011-0242-4. Epub 2012 Jan 19. |
heart left ventricular blood pressure trait |
male |
84 days
| 5 |
|
|
131.0 |
mmHg |
3.0 |
6.71 |
vascular indwelling catheter method |
heart left ventricle |
0.0 |
|
0 |
|
|
|
|
108775 |
3130 |
HsdCpb:WU |
mean arterial blood pressure |
left anterior descending coronary artery occlusion |
Szymanski MK, etal., Basic Res Cardiol. 2012 Mar;107(2):242. doi: 10.1007/s00395-011-0242-4. Epub 2012 Jan 19. |
arterial blood pressure trait |
male |
175 days
| 6 |
|
|
88.0 |
mmHg |
4.0 |
9.8 |
vascular indwelling catheter method |
aorta |
0.0 |
|
0 |
|
|
|
|
108843 |
3130 |
MWF |
mean arterial blood pressure |
controlled enalapril content drinking water (10 mg/kg) (for 28 days) |
Schie?l IM, etal., J Pharmacol Exp Ther. 2015 May;353(2):299-306. doi: 10.1124/jpet.114.222125. Epub 2015 Feb 13. |
arterial blood pressure trait |
male |
364 days
| 6 |
|
|
110.9 |
mmHg |
0.6 |
1.47 |
vascular indwelling catheter method |
right common carotid artery plus branches |
0.0 |
|
0 |
|
|
|
|
108052 |
3113 |
SR/Hsd |
range of heart rate variation during variation of mean arterial blood pressure |
aldosterone (22.5 ng/hr) (for 14 days) and artificial cerebrospinal fluid with 0.15 M sodium (4.4-4.6 ul/hr) (for 14 days) |
Huang BS, et al., Am J Physiol Heart Circ Physiol. 2005 Feb;288(2):H517-24. doi: 10.1152/ajpheart.00651.2004. Epub 2004 Sep 30. |
heart pumping trait |
male |
52 days-61 days |
8 |
|
|
226.0 |
beats/min |
17.0 |
48.08 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
change in heart rate to change in mean arterial blood pressure ratio (range) (CMO:0003896) |
|
138431 |
2801 |
SS/Hsd |
mean arterial pressure at the midpoint of a range of renal sympathetic nerve activity |
aldosterone (22.5 ng/hr) (for 14 days) and artificial cerebrospinal fluid with 0.15 M sodium (4.4-4.6 ul/hr) (for 14 days) |
Huang BS, et al., Am J Physiol Heart Circ Physiol. 2005 Feb;288(2):H517-24. doi: 10.1152/ajpheart.00651.2004. Epub 2004 Sep 30. |
arterial blood pressure trait |
male |
52 days-61 days |
8 |
|
|
131.0 |
mmHg |
4.0 |
11.31 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
138429 |
2801 |
MWF |
mean arterial blood pressure |
castor oil |
Fassi A, etal., Am J Kidney Dis. 1999 Feb;33(2):267-75. doi: 10.1016/s0272-6386(99)70299-4. |
arterial blood pressure trait |
male |
133 days-147 days |
7 |
|
|
122.0 |
mmHg |
2.65 |
7.0 |
vascular indwelling catheter method |
femoral artery |
0.0 |
|
0 |
|
|
|
|
110076 |
3163 |
MWF |
mean arterial blood pressure |
cyclosporine A (50 mg/kg/d) (for 7 days) and lacidipine (1 mg/kg/d) (for 7 days) |
Fassi A, etal., Am J Kidney Dis. 1999 Feb;33(2):267-75. doi: 10.1016/s0272-6386(99)70299-4. |
arterial blood pressure trait |
male |
133 days-147 days |
7 |
|
|
96.0 |
mmHg |
2.65 |
7.0 |
vascular indwelling catheter method |
femoral artery |
0.0 |
|
0 |
|
|
|
|
110078 |
3163 |
SS/Hsd |
heart rate |
aldosterone (22.5 ng/hr) (for 14 days) and artificial cerebrospinal fluid with 0.15 M sodium (4.4-4.6 ul/hr) (for 14 days) |
Huang BS, et al., Am J Physiol Heart Circ Physiol. 2005 Feb;288(2):H517-24. doi: 10.1152/ajpheart.00651.2004. Epub 2004 Sep 30. |
heart pumping trait |
male |
49 days-57 days |
0 |
|
|
490.0 |
beats/min |
10.0 |
|
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
138450 |
2801 |
SS/Hsd |
percent change in heart rate |
aldosterone (22.5 ng/hr) (for 14 days) and artificial cerebrospinal fluid with 0.15 M sodium (4.4-4.6 ul/hr) (for 14 days) then air-jet exposure (1-1.5 lb/in2) (for 0 hours) |
Huang BS, et al., Am J Physiol Heart Circ Physiol. 2005 Feb;288(2):H517-24. doi: 10.1152/ajpheart.00651.2004. Epub 2004 Sep 30. |
heart pumping trait |
male |
49 days-56 days |
0 |
|
|
8.0 |
% |
0.7 |
|
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
138371 |
2801 |
SS/Hsd |
heart rate |
aldosterone (22.5 ng/hr) (for 14 days) and artificial cerebrospinal fluid with 0.15 M sodium (4.4-4.6 ul/hr) (for 14 days) |
Huang BS, et al., Am J Physiol Heart Circ Physiol. 2005 Feb;288(2):H517-24. doi: 10.1152/ajpheart.00651.2004. Epub 2004 Sep 30. |
heart pumping trait |
male |
49 days-57 days |
0 |
|
|
499.0 |
beats/min |
15.0 |
|
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
138377 |
2801 |
SR/Hsd |
mean arterial blood pressure |
aldosterone (22.5 ng/hr) (for 14 days) and artificial cerebrospinal fluid with 0.15 M sodium (4.4-4.6 ul/hr) (for 14 days) |
Huang BS, et al., Am J Physiol Heart Circ Physiol. 2005 Feb;288(2):H517-24. doi: 10.1152/ajpheart.00651.2004. Epub 2004 Sep 30. |
arterial blood pressure trait |
male |
52 days-61 days |
0 |
|
|
110.0 |
mmHg |
2.0 |
|
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
138367 |
2801 |
SS/Hsd |
heart rate |
artificial cerebrospinal fluid with 0.15 M sodium (4.4-4.6 ul/hr) (for 14 days) |
Huang BS, et al., Am J Physiol Heart Circ Physiol. 2005 Feb;288(2):H517-24. doi: 10.1152/ajpheart.00651.2004. Epub 2004 Sep 30. |
heart pumping trait |
male |
49 days-57 days |
0 |
|
|
453.0 |
beats/min |
13.0 |
|
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
138376 |
2801 |
SR/Hsd |
mean arterial pressure at the midpoint of a range of heart rates |
artificial cerebrospinal fluid with 0.15 M sodium (4.4-4.6 ul/hr) (for 14 days) |
Huang BS, et al., Am J Physiol Heart Circ Physiol. 2005 Feb;288(2):H517-24. doi: 10.1152/ajpheart.00651.2004. Epub 2004 Sep 30. |
arterial blood pressure trait |
male |
52 days-61 days |
6 |
|
|
106.0 |
mmHg |
3.0 |
7.35 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
138438 |
2801 |
SS/Hsd |
percent change in mean arterial blood pressure |
artificial cerebrospinal fluid with 0.15 M sodium (4.4-4.6 ul/hr) (for 14 days) then Guanabenz (50 ug) (between 0 and 0.3 hours) |
Huang BS, et al., Am J Physiol Heart Circ Physiol. 2005 Feb;288(2):H517-24. doi: 10.1152/ajpheart.00651.2004. Epub 2004 Sep 30. |
arterial blood pressure trait |
male |
52 days-61 days |
0 |
|
|
-10.0 |
% |
1.0 |
|
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
138442 |
2801 |
SS/Hsd |
percent change in mean arterial blood pressure |
aldosterone (22.5 ng/hr) (for 14 days) and artificial cerebrospinal fluid with 0.15 M sodium (4.4-4.6 ul/hr) (for 14 days) then Guanabenz (50 ug) (between 0 and 0.3 hours) |
Huang BS, et al., Am J Physiol Heart Circ Physiol. 2005 Feb;288(2):H517-24. doi: 10.1152/ajpheart.00651.2004. Epub 2004 Sep 30. |
arterial blood pressure trait |
male |
52 days-61 days |
0 |
|
|
-18.0 |
% |
2.0 |
|
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
138443 |
2801 |
BN/Elh |
diastolic blood pressure |
control condition |
Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. |
arterial blood pressure trait |
male |
127 days-143 days |
21 |
|
serial mean |
85.3 |
mmHg |
2.62 |
12.0 |
vascular indwelling catheter method |
left femoral artery and vein |
4 hrs/day for 3 days |
|
0 |
|
microrenathane catheter; recover for 1 week after surgery |
|
|
11551 |
101 |
SS/JrHsdMcwi |
mean arterial blood pressure |
controlled sodium content diet (0.4 %) (for 28 days) then controlled sodium content diet (8 %) (for 31 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 1.5 days) then controlled exposure to ambient light (for 12 hours) |
Cowley AW Jr, et al., Physiol Genomics 2000 Apr 27;2(3):107-15. |
arterial blood pressure trait |
male |
96 days
| 24 |
|
continuous mean |
141.0 |
mmHg |
5.0 |
24.49 |
vascular indwelling catheter method |
femoral artery |
10800.0 |
|
0 |
|
left femoral artery |
|
|
12038 |
229 |
LEW |
mean arterial blood pressure |
losartan (10 mg/kg) (for 0.2 hours) then pentolinium (5 mg/kg) (for 0.1 hours) then NG-nitroarginine methyl ester (30 mg/kg) (for 0.3 hours) |
Ueno T, et al., J Mol Med 2003 Jan;81(1):51-60. Epub 2002 Nov 21. |
arterial blood pressure trait |
both |
151 days-181 days |
21 |
|
continuous mean |
123.0 |
mmHg |
5.0 |
22.91 |
vascular indwelling catheter method |
carotid artery, jugular vein |
1800 |
|
0 |
|
|
|
|
64706 |
249 |
Crl:WI |
diastolic blood pressure |
control condition |
Blanc J, et al., J Hypertens. 1999 Nov;17(11):1527-34. |
arterial blood pressure trait |
male |
0 days
| 13 |
|
|
96.0 |
mmHg |
3.0 |
10.82 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
70416 |
1418 |
WKY.WKHA-(D5Rat45-D5Rat245)/Cfd |
maximum rate of negative change in left ventricular blood pressure |
artificial aortocaval fistula |
Souzeau E, et al., Hypertension. 2006 Jan;47(1):128-33. Epub 2005 Dec 12. |
heart left ventricular blood pressure trait |
female |
84 days-154 days |
5 |
|
|
7195.0 |
mmHg/s |
480.0 |
1073.31 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
68913 |
1014 |
BN/NHsdMcwi |
heart rate |
controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (between 22 and 24 days) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
heart pumping trait |
female |
93 days
| 20 |
|
serial mean |
369.9 |
beats/min |
5.1 |
22.81 |
vascular indwelling catheter method |
left femoral artery |
10800.0 |
|
0 |
|
|
|
|
69519 |
151 |
SS/JrHsdMcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 21 days) |
Mattson DL, et al., Am J Physiol Regul Integr Comp Physiol. 2013 Jan 30. |
arterial blood pressure trait |
not specified |
84 days
| 4 |
|
|
181.0 |
mmHg |
9.0 |
18.0 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
69292 |
1057 |
WKY/NCrl |
systolic blood pressure |
controlled sodium content diet (8 %) (for 14 days) then controlled exposure to ambient light (for 14 days) |
Iwai N, et al., Circulation 1999 Nov 2;100(18):1923-9. |
arterial blood pressure trait |
male |
126 days
| 7 |
|
|
126.4 |
mmHg |
1.06 |
2.8 |
vascular indwelling catheter method |
left common carotid artery |
0.0 |
|
0 |
|
|
daytime (7 AM - 7 PM) |
|
70085 |
1281 |
WKY/NCrl |
diastolic blood pressure |
controlled sodium content diet (8 %) (for 14 days) then controlled exposure to darkness (for 12 hours) |
Iwai N, et al., Circulation 1999 Nov 2;100(18):1923-9. |
arterial blood pressure trait |
male |
126 days
| 7 |
|
|
93.9 |
mmHg |
1.29 |
3.4 |
vascular indwelling catheter method |
left common carotid artery |
0.0 |
|
0 |
|
|
nighttime (7 PM - 7 AM) |
|
70088 |
1281 |
WKY/Cfd |
left ventricular end-diastolic blood pressure |
sham surgical control condition |
Souzeau E, et al., Hypertension. 2006 Jan;47(1):128-33. Epub 2005 Dec 12. |
heart left ventricular blood pressure trait |
male |
84 days-154 days |
5 |
|
|
1.32 |
mmHg |
0.3 |
0.67 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
68802 |
1014 |
WKHA/Cfd |
left ventricular end-diastolic blood pressure |
artificial aortocaval fistula |
Souzeau E, et al., Hypertension. 2006 Jan;47(1):128-33. Epub 2005 Dec 12. |
heart left ventricular blood pressure trait |
male |
84 days-154 days |
5 |
|
|
0.28 |
mmHg |
0.37 |
0.83 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
68805 |
1014 |
WKY/Cfd |
left ventricular end-diastolic blood pressure |
sham surgical control condition |
Souzeau E, et al., Hypertension. 2006 Jan;47(1):128-33. Epub 2005 Dec 12. |
heart left ventricular blood pressure trait |
female |
84 days-154 days |
5 |
|
|
1.66 |
mmHg |
0.62 |
1.39 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
68808 |
1014 |
WKY.SHRSP-(D1Wox29-D1Arb21)/Izm |
absolute change in mean arterial blood pressure |
air-jet exposure (for 0 hours) then hexamethonium (40 mg/kg) |
Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. |
arterial blood pressure trait |
male |
98 days
| 6 |
|
|
-48.0 |
mmHg |
6.0 |
14.7 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
69090 |
1120 |
WKY/Izm |
heart rate |
control condition |
Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. |
heart pumping trait |
male |
98 days
| 6 |
|
|
317.0 |
beats/min |
14.0 |
34.29 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
69086 |
1120 |
SD-Trpv1em1Sage+/+ |
mean arterial blood pressure |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion (for 0.5 hours) then cyclosporine A (2.5 mg/kg) (for 3.2 hours) then Myocardial reperfusion (for 2 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
arterial blood pressure trait |
male |
56 days-70 days |
6 |
|
|
78.0 |
mmHg |
3.0 |
7.35 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
104728 |
2988 |
SD-Trpv1em1Sage+/+ |
mean arterial blood pressure |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion then Capsazepine (3 mg/kg) (for 0.7 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
arterial blood pressure trait |
male |
56 days-70 days |
5 |
|
|
129.0 |
mmHg |
6.0 |
13.42 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
104682 |
2988 |
SD-Trpv1em1Sage+/+ |
heart rate |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion (for 0.5 hours) then dihydrocapsaicin (0.3 mg/kg) (for 3.2 hours) then Myocardial reperfusion (for 2 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
heart pumping trait |
male |
56 days-70 days |
6 |
|
|
368.0 |
beats/min |
6.0 |
14.7 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
104704 |
2988 |
SD-Trpv1em1Sage+/+ |
mean arterial blood pressure |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion (for 0.2 hours) then dihydrocapsaicin (1 mg/kg) (for 0.9 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
arterial blood pressure trait |
male |
56 days-70 days |
6 |
|
|
104.0 |
mmHg |
10.0 |
24.49 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
104714 |
2988 |
MW |
mean arterial blood pressure |
control condition |
Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. |
arterial blood pressure trait |
male |
0 days
| 18 |
undefined |
|
106.0 |
mmHg |
3.0 |
12.73 |
vascular indwelling catheter method |
|
0.0 |
control |
29 |
days |
|
|
|
101176 |
2581 |
WKY/Izm |
absolute change in heart rate |
air-jet exposure (for 0 hours) then vehicle control condition (2 ul) (for 0 hours) |
Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. |
heart pumping trait |
male |
98 days
| 6 |
|
|
0.0 |
beats/min |
6.0 |
14.7 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
84562 |
1120 |
SHR.BN-(D2Rat114-D2Rat123)/Jk |
diastolic blood pressure |
controlled sodium content drinking water (1 %) (for 15 days) |
Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6. |
arterial blood pressure trait |
male |
99 days
| 23 |
|
continuous mean |
133.0 |
mmHg |
2.0 |
9.59 |
vascular indwelling catheter method |
femoral artery |
1800 |
|
0 |
|
pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH) |
|
|
65343 |
306 |
SHR.BN-(D2Rat114-D2Rat123)/Jk |
mean arterial blood pressure |
controlled sodium content drinking water (1 %) (for 15 days) |
Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6. |
arterial blood pressure trait |
male |
99 days
| 23 |
|
continuous mean |
156.0 |
mmHg |
3.0 |
14.39 |
vascular indwelling catheter method |
femoral artery |
1800 |
|
0 |
|
pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH) |
|
|
65344 |
306 |
SHR |
heart rate |
controlled sodium content diet (1 %) (for 14 days) |
Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6. |
heart pumping trait |
male |
87 days
| 24 |
|
continuous mean |
380.0 |
beats/min |
8.0 |
39.19 |
vascular indwelling catheter method |
femoral artery |
1800 |
|
0 |
|
pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH) |
|
|
65346 |
306 |
SHR |
mean arterial blood pressure |
controlled sodium content drinking water (1 %) (for 15 days) |
Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6. |
arterial blood pressure trait |
male |
99 days
| 24 |
|
continuous mean |
170.0 |
mmHg |
3.0 |
14.7 |
vascular indwelling catheter method |
femoral artery |
1800 |
|
0 |
|
pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH) |
|
|
65348 |
306 |
SHR |
mean arterial blood pressure |
control condition |
Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6. |
arterial blood pressure trait |
male |
99 days
| 23 |
|
continuous mean |
162.0 |
mmHg |
2.0 |
9.59 |
vascular indwelling catheter method |
femoral artery |
1800 |
|
0 |
|
pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH) |
|
|
65350 |
306 |
F344/NHsd |
mean pulmonary arterial blood pressure |
control condition |
Zhao L et al., 2001, Circulation, 103(3), 442-7 |
pulmonary arterial blood pressure trait |
male |
105 days
| 12 |
|
median |
16.0 |
mmHg |
|
|
vascular indwelling catheter method |
pulmonary artery |
0 |
|
0 |
|
|
|
|
66123 |
102 |
SS/JrHsdMcwi |
absolute change in mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then angiotensin II (200 ng/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101 days-103 days |
13 |
|
serial mean |
34.0 |
mmHg |
3.0 |
10.82 |
vascular indwelling catheter method |
left femoral artery |
0.0 |
|
0 |
|
|
|
|
67300 |
151 |
SHR/NCruk |
systolic blood pressure |
control condition |
Frantz S, et al., Hypertension 2001 Aug;38(2):216-21 |
arterial blood pressure trait |
male |
196 days
| 15 |
|
|
205.3 |
mmHg |
3.3 |
12.8 |
vascular indwelling catheter method |
|
|
|
0 |
|
beat to beat for 1 hour |
|
|
11328 |
72 |
LH/Mav |
systolic blood pressure |
control condition |
Dubay C, et al., Nat Genet 1993 Apr;3(4):354-7 |
arterial blood pressure trait |
male |
203 days-217 days |
16 |
|
serial mean |
174.1 |
mmHg |
|
|
vascular indwelling catheter method |
abdominal aorta |
10800 |
|
0 |
|
|
|
|
11645 |
111 |
WKY.SHR-(D1Rat236-D1M7Mit206)/Njs |
diastolic blood pressure |
control condition |
Frantz S, et al., Hypertension 2001 Aug;38(2):216-21 |
arterial blood pressure trait |
male |
196 days
| 15 |
|
|
114.3 |
mmHg |
2.07 |
8.0 |
vascular indwelling catheter method |
|
|
|
0 |
|
beat to beat for 1 hour |
|
|
11335 |
72 |
LH/MavRrrc |
absolute change in systolic blood pressure |
trimethaphan camsylate (10 mg/kg) (for 0.2 hours) |
Vincent M, et al., J Clin Invest 1997 Oct 15;100(8):2000-6 |
arterial blood pressure trait |
not specified |
203 days-217 days |
16 |
|
serial mean |
-63.0 |
mmHg |
2.17 |
8.7 |
vascular indwelling catheter method |
abdominal aorta |
3600 |
|
0 |
|
|
|
|
65264 |
121 |
LH/MavRrrc |
absolute change in diastolic blood pressure |
darodipine (200 ug/kg) (for 0.2 hours) |
Vincent M, et al., J Clin Invest 1997 Oct 15;100(8):2000-6 |
arterial blood pressure trait |
not specified |
203 days-217 days |
16 |
|
serial mean |
-70.4 |
mmHg |
1.93 |
7.7 |
vascular indwelling catheter method |
abdominal aorta |
3600 |
|
0 |
|
|
|
|
65270 |
121 |
BN/NHsdMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (0.4 %) (for 28 days) then controlled sodium content diet (8 %) (for 30 days) then controlled exposure to ambient light (for 12 hours) then controlled exposure to darkness (for 12 hours) |
Cowley AW Jr, et al., Physiol Genomics 2000 Apr 27;2(3):107-15. |
arterial blood pressure trait |
male |
91 days-93 days |
42 |
|
continuous mean |
4.5 |
mmHg |
2.0 |
12.96 |
vascular indwelling catheter method |
femoral artery |
0.0 |
|
0 |
|
left femoral artery |
increase |
|
64928 |
229 |
SS/JrHsdMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) then tactile electric shock exposure (2 %) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
92 days-94 days |
8 |
|
serial mean |
11.0 |
mmHg |
3.0 |
8.49 |
vascular indwelling catheter method |
left femoral artery |
0 |
|
0 |
|
|
|
|
66150 |
151 |
LEW |
mean arterial blood pressure |
losartan (10 mg/kg) (for 0.2 hours) |
Ueno T, et al., J Mol Med 2003 Jan;81(1):51-60. Epub 2002 Nov 21. |
arterial blood pressure trait |
both |
151 days-181 days |
21 |
|
continuous mean |
102.0 |
mmHg |
2.0 |
9.17 |
vascular indwelling catheter method |
carotid artery, jugular vein |
1800 |
|
0 |
|
|
|
|
12393 |
249 |
MNS/Gib |
systolic blood pressure |
control condition |
Zagato et al., 2000, Hypertension, 36(5), 734-9 |
arterial blood pressure trait |
not specified |
112 days
| 14 |
|
continuous mean |
138.3 |
mmHg |
2.8 |
10.48 |
vascular indwelling catheter method |
carotid artery |
1 min tracing every 3-4 min for 1 h |
|
0 |
|
Gould BS3200 BP recorder |
|
|
11723 |
122 |
BN/NHsdMcwi |
diastolic blood pressure |
controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (between 22 and 24 days) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
89 days-92 days |
21 |
|
serial mean |
92.0 |
mmHg |
3.0 |
13.75 |
vascular indwelling catheter method |
left femoral artery |
|
|
0 |
|
3 hrs (during inactive phase) 3 consecutive days, and 4 extra hrs (during active phase) next day |
|
|
11851 |
151 |
BN.GH-(D18Rat41-D18Mgh4)/Mcwi |
heart rate |
control condition |
Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. |
heart pumping trait |
male |
127 days-143 days |
21 |
|
serial mean |
361.7 |
beats/min |
7.2 |
33.0 |
vascular indwelling catheter method |
left femoral artery and vein |
4 hrs/day for 3 days |
|
0 |
|
microrenathane catheter; recover for 1 week after surgery |
|
|
11545 |
101 |
GH/Omr |
systolic blood pressure |
control condition |
Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. |
arterial blood pressure trait |
male |
127 days-143 days |
21 |
|
serial mean |
190.9 |
mmHg |
2.12 |
9.7 |
vascular indwelling catheter method |
left femoral artery and vein |
4 hrs/day for 3 days |
|
0 |
|
microrenathane catheter; recover for 1 week after surgery |
|
|
11522 |
101 |
BN/Elh |
systolic blood pressure |
control condition |
Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. |
arterial blood pressure trait |
male |
127 days-143 days |
21 |
|
serial mean |
116.4 |
mmHg |
1.7 |
7.8 |
vascular indwelling catheter method |
left femoral artery and vein |
4 hrs/day for 3 days |
|
0 |
|
microrenathane catheter; recover for 1 week after surgery |
|
|
11550 |
101 |
BN/NHsdMcwi |
systolic blood pressure |
controlled sodium content diet (0.1 %) (for 28 days) then controlled sodium content diet (8 %) (for 31 days) and controlled exposure to ambient light (for 12 hours) |
Cowley AW Jr, et al., Physiol Genomics 2000 Apr 27;2(3):107-15. |
arterial blood pressure trait |
male |
91 days-94 days |
42 |
|
continuous mean |
127.0 |
mmHg |
3.0 |
19.44 |
vascular indwelling catheter method |
femoral artery |
259200.0 |
|
0 |
|
3 h per day |
|
|
12006 |
229 |
SS/JrHsdMcwi |
mean arterial blood pressure |
controlled sodium content diet (0.4 %) |
Cowley AW Jr, et al., Physiol Genomics 2000 Apr 27;2(3):107-15. |
arterial blood pressure trait |
male |
84 days
| 28 |
|
continuous mean |
125.0 |
mmHg |
3.0 |
15.87 |
vascular indwelling catheter method |
femoral artery |
3.0 |
|
0 |
|
left femoral artery |
|
|
12024 |
229 |
BN/NHsdMcwi |
mean arterial blood pressure |
controlled sodium content diet (0.4 %) (for 28 days) then controlled sodium content diet (8 %) (for 31 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 1.5 days) then controlled exposure to ambient light (for 12 hours) |
Cowley AW Jr, et al., Physiol Genomics 2000 Apr 27;2(3):107-15. |
arterial blood pressure trait |
male |
96 days
| 21 |
|
continuous mean |
96.0 |
mmHg |
3.0 |
13.75 |
vascular indwelling catheter method |
femoral artery |
10800.0 |
|
0 |
|
left femoral artery |
|
|
13275 |
229 |
SHRSP/Bbb |
heart rate |
control condition |
Kreutz R, et al., Circulation 1997 Aug 19;96(4):1078-81. |
heart pumping trait |
female |
112 days
| 11 |
|
serial mean |
416.0 |
beats/min |
9.65 |
32.0 |
vascular indwelling catheter method |
femoral artery |
|
|
0 |
|
|
3 sets of readings per day for two days |
|
13289 |
334 |
SHRSP/Bbb |
heart rate |
controlled sodium content drinking water (1 %) (between 13 and 15 days) |
Kreutz R, et al., Circulation 1997 Aug 19;96(4):1078-81. |
heart pumping trait |
male |
125 days-127 days |
12 |
|
serial mean |
433.0 |
beats/min |
4.33 |
15.0 |
vascular indwelling catheter method |
femoral artery |
|
|
0 |
|
|
3 sets of readings per day for two days |
|
13290 |
334 |
BN/NHsdMcwi |
heart rate |
controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (for 21 days) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
heart pumping trait |
female |
89 days-92 days |
20 |
|
serial mean |
367.0 |
beats/min |
5.0 |
22.36 |
vascular indwelling catheter method |
left femoral artery |
|
|
0 |
|
3 hrs (during inactive phase) 3 consecutive days, and 4 extra hrs (during active phase) next day |
|
|
13309 |
151 |
SHR.BN-(D2Rat226-D2Rat294)/Jk |
mean arterial blood pressure |
controlled sodium content drinking water (1 %) (for 15 days) |
Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6. |
arterial blood pressure trait |
male |
99 days
| 22 |
|
continuous mean |
154.0 |
mmHg |
2.0 |
9.38 |
vascular indwelling catheter method |
femoral artery |
1800 |
|
0 |
|
pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH) |
|
|
65403 |
306 |
SHR.BN-(D4Rat33-D4Rat54)/Jk |
mean arterial blood pressure |
controlled sodium content drinking water (1 %) (for 15 days) |
Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6. |
arterial blood pressure trait |
male |
99 days
| 23 |
|
continuous mean |
162.0 |
mmHg |
2.0 |
9.59 |
vascular indwelling catheter method |
femoral artery |
1800 |
|
0 |
|
pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH) |
|
|
65409 |
306 |
SHR.BN-(D16Rat87-D16Mgh1)/Jk |
systolic blood pressure |
control condition |
Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6. |
arterial blood pressure trait |
male |
99 days
| 22 |
|
continuous mean |
181.0 |
mmHg |
2.0 |
9.38 |
vascular indwelling catheter method |
femoral artery |
1800 |
|
0 |
|
pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH) |
|
|
65411 |
306 |
WKY/NCruk |
mean pulmonary arterial blood pressure |
air oxygen content (10 %) (for 21 days) |
Zhao L et al., 2001, Circulation, 103(3), 442-7 |
pulmonary arterial blood pressure trait |
male |
105 days
| 28 |
|
median |
38.0 |
mmHg |
|
|
vascular indwelling catheter method |
pulmonary artery |
0 |
|
0 |
|
|
|
|
66126 |
102 |
BN.GH-(D18Rat41-D18Mgh4)/Mcwi |
change in mean arterial blood pressure to change in vasoactive chemical dose ratio |
angiotensin II (5-50 ng/kg/min) (between 0.2 and 1 hours) |
Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. |
arterial blood pressure trait |
male |
130 days-144 days |
11 |
|
|
0.71 |
mmHg/ng/kg/min |
0.02 |
0.07 |
vascular indwelling catheter method |
left femoral artery and vein |
0.0 |
|
0 |
|
microrenathane catheter; recover for 1 week after surgery |
slope of map response curve |
|
68342 |
101 |
WKY.WKHA-(D5Rat45-D5Rat245)/Cfd |
left ventricular end-diastolic blood pressure |
artificial aortocaval fistula |
Souzeau E, et al., Hypertension. 2006 Jan;47(1):128-33. Epub 2005 Dec 12. |
heart left ventricular blood pressure trait |
male |
84 days-154 days |
5 |
|
|
0.33 |
mmHg |
0.32 |
0.72 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
68807 |
1014 |
WKY.SHRSP-(D1Wox29-D1Arb21)/Izm |
heart rate |
control condition |
Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. |
heart pumping trait |
male |
98 days
| 6 |
|
|
321.0 |
beats/min |
11.0 |
26.94 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
69087 |
1120 |
SHRSP/Izm |
absolute change in mean arterial blood pressure |
air-jet exposure (for 0 hours) then hexamethonium (40 mg/kg) |
Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. |
arterial blood pressure trait |
male |
98 days
| 6 |
|
|
-102.0 |
mmHg |
5.0 |
12.25 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
69091 |
1120 |
SS/JrHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then angiotensin II (200 ng/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101 days-103 days |
13 |
|
serial mean |
160.2 |
mmHg |
3.5 |
12.62 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
0 |
|
|
|
|
69534 |
151 |
BN/NHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then acetylcholine (0.1 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101 days-103 days |
21 |
|
serial mean |
111.3 |
mmHg |
4.6 |
21.08 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
0 |
|
|
|
|
69541 |
151 |
SS/JrHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then NG-nitroarginine methyl ester (5 mg/kg) then acetylcholine (0.2 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101 days-103 days |
9 |
|
serial mean |
159.1 |
mmHg |
6.4 |
19.2 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
0 |
|
|
|
|
69550 |
151 |
BN/NHsdMcwi |
systolic blood pressure |
controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (between 22 and 24 days) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
92 days
| 20 |
|
serial mean |
140.6 |
mmHg |
4.4 |
19.68 |
vascular indwelling catheter method |
left femoral artery |
10800.0 |
|
0 |
|
|
|
|
69509 |
151 |
BN/NHsdMcwi |
systolic blood pressure |
controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (between 22 and 24 days) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
93 days
| 21 |
|
serial mean |
127.2 |
mmHg |
4.1 |
18.79 |
vascular indwelling catheter method |
left femoral artery |
10800.0 |
|
0 |
|
|
|
|
69515 |
151 |
SS/JrHsdMcwi |
heart rate |
controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (between 22 and 24 days) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
heart pumping trait |
female |
94 days
| 10 |
|
serial mean |
411.7 |
beats/min |
10.6 |
33.52 |
vascular indwelling catheter method |
left femoral artery |
10800.0 |
|
0 |
|
|
|
|
69526 |
151 |
WKHA/Cfd |
left ventricular end-diastolic blood pressure |
artificial aortocaval fistula |
Souzeau E, et al., Hypertension. 2006 Jan;47(1):128-33. Epub 2005 Dec 12. |
heart left ventricular blood pressure trait |
female |
84 days-154 days |
5 |
|
|
0.62 |
mmHg |
0.73 |
1.63 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
68858 |
1014 |
WKHA/Cfd |
left ventricular end-systolic blood pressure |
sham surgical control condition |
Souzeau E, et al., Hypertension. 2006 Jan;47(1):128-33. Epub 2005 Dec 12. |
heart left ventricular blood pressure trait |
male |
84 days-154 days |
5 |
|
|
126.0 |
mmHg |
5.17 |
11.56 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
68863 |
1014 |
WKY/Cfd |
left ventricular end-systolic blood pressure |
sham surgical control condition |
Souzeau E, et al., Hypertension. 2006 Jan;47(1):128-33. Epub 2005 Dec 12. |
heart left ventricular blood pressure trait |
female |
84 days-154 days |
5 |
|
|
129.7 |
mmHg |
0.8 |
1.79 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
68867 |
1014 |
WKHA/Cfd |
maximum rate of positive change in left ventricular blood pressure |
artificial aortocaval fistula |
Souzeau E, et al., Hypertension. 2006 Jan;47(1):128-33. Epub 2005 Dec 12. |
heart left ventricular blood pressure trait |
male |
84 days-154 days |
5 |
|
|
9597.0 |
mmHg/s |
465.0 |
1039.77 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
68893 |
1014 |
WKY/Cfd |
maximum rate of positive change in left ventricular blood pressure |
sham surgical control condition |
Souzeau E, et al., Hypertension. 2006 Jan;47(1):128-33. Epub 2005 Dec 12. |
heart left ventricular blood pressure trait |
female |
84 days-154 days |
5 |
|
|
10672.0 |
mmHg/s |
343.0 |
766.97 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
68896 |
1014 |
WKY.WKHA-(D5Rat45-D5Rat245)/Cfd |
maximum rate of positive change in left ventricular blood pressure |
artificial aortocaval fistula |
Souzeau E, et al., Hypertension. 2006 Jan;47(1):128-33. Epub 2005 Dec 12. |
heart left ventricular blood pressure trait |
female |
84 days-154 days |
5 |
|
|
9982.0 |
mmHg/s |
250.0 |
559.02 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
68901 |
1014 |
WKY.WKHA-(D5Rat45-D5Rat245)/Cfd |
maximum rate of negative change in left ventricular blood pressure |
artificial aortocaval fistula |
Souzeau E, et al., Hypertension. 2006 Jan;47(1):128-33. Epub 2005 Dec 12. |
heart left ventricular blood pressure trait |
male |
84 days-154 days |
5 |
|
|
7490.0 |
mmHg/s |
227.0 |
507.59 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
68907 |
1014 |
BN/NHsdMcwi |
mean arterial blood pressure |
controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (between 22 and 24 days) then controlled exposure to darkness (for 12 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
89 days-91 days |
20 |
|
serial mean |
111.0 |
mmHg |
2.7 |
12.07 |
vascular indwelling catheter method |
left femoral artery |
0.0 |
|
0 |
|
|
|
|
69447 |
151 |
WKY/NCrl |
diastolic blood pressure |
controlled exposure to darkness (for 12 hours) |
Iwai N, et al., Circulation 1999 Nov 2;100(18):1923-9. |
arterial blood pressure trait |
male |
112 days
| 7 |
|
|
92.5 |
mmHg |
1.59 |
4.2 |
vascular indwelling catheter method |
left common carotid artery |
0.0 |
|
0 |
|
|
nighttime (7 PM - 7 AM) |
|
70084 |
1281 |
WKY/NCrl |
systolic blood pressure |
controlled sodium content diet (8 %) (for 14 days) then controlled exposure to darkness (for 12 hours) |
Iwai N, et al., Circulation 1999 Nov 2;100(18):1923-9. |
arterial blood pressure trait |
male |
126 days
| 7 |
|
|
131.7 |
mmHg |
0.83 |
2.2 |
vascular indwelling catheter method |
left common carotid artery |
0.0 |
|
0 |
|
|
nighttime (7 PM - 7 AM) |
|
70086 |
1281 |
WKY.SHR-(D1Mgh14-D1Rat77)/Iwai |
diastolic blood pressure |
controlled exposure to darkness (for 12 hours) |
Iwai N, et al., Circulation 1999 Nov 2;100(18):1923-9. |
arterial blood pressure trait |
male |
112 days
| 8 |
|
|
94.6 |
mmHg |
0.99 |
2.8 |
vascular indwelling catheter method |
left common carotid artery |
0.0 |
|
0 |
|
|
nighttime (7 PM - 7 AM) |
|
70092 |
1281 |
WKY.SHRSP-(D1Wox29-D1Arb21)/Izm |
absolute change in mean arterial blood pressure |
air-jet exposure (for 0 hours) then candesartan (1 ug) (for 0 hours) |
Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. |
arterial blood pressure trait |
male |
98 days
| 6 |
|
|
-10.0 |
mmHg |
1.0 |
2.45 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
85199 |
1120 |
FHH.PCK-(D9Rat35-D9Rat70)/Mcwi |
mean arterial blood pressure |
control condition |
O'Meara CC, et al., Physiol Genomics. 2012 Aug 1;44(15):741-53. doi: 10.1152/physiolgenomics.00187.2011. Epub 2012 Jun 5. |
arterial blood pressure trait |
male |
189 days
| 8 |
|
serial mean |
124.0 |
mmHg |
4.0 |
11.31 |
vascular indwelling catheter method |
femoral artery |
10800.0 |
|
0 |
|
1day/week |
|
|
96902 |
1738 |
WKY.SHRSP-(D1Wox29-D1Arb21)/Izm |
percent change in mean arterial blood pressure |
air-jet exposure (for 0 hours) |
Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. |
arterial blood pressure trait |
male |
98 days
| 6 |
|
|
33.0 |
% |
3.0 |
7.35 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
84543 |
1120 |
WKY/Izm |
absolute change in mean arterial blood pressure |
air-jet exposure (for 0 hours) then vehicle control condition (2 ul) (for 0 hours) |
Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. |
arterial blood pressure trait |
male |
98 days
| 6 |
|
|
-3.0 |
mmHg |
2.0 |
4.9 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
84553 |
1120 |
WKY/Izm |
absolute change in heart rate |
air-jet exposure (for 0 hours) |
Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. |
heart pumping trait |
male |
98 days
| 6 |
|
|
85.0 |
beats/min |
8.0 |
19.6 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
84558 |
1120 |
SR/JrIpcv |
systolic blood pressure |
controlled sodium content diet (0.3 %) |
Hojn¿ S, et al., Physiol Res. 2005;54(2):201-6. |
arterial blood pressure trait |
male |
0 days
| 0 |
undefined |
|
137.0 |
mmHg |
3.0 |
|
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
102395 |
2688 |
SS/JrIpcv |
mean arterial blood pressure |
controlled sodium content diet (0.3 %) |
Hojn¿ S, et al., Physiol Res. 2005;54(2):201-6. |
arterial blood pressure trait |
male |
0 days
| 0 |
undefined |
|
131.0 |
mmHg |
3.0 |
|
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
102398 |
2688 |
SD-Trpv1em1Sage+/+ |
heart rate |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion then dihydrocapsaicin (0.1 mg/kg) (for 0.7 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
heart pumping trait |
male |
56 days-70 days |
6 |
|
|
377.0 |
beats/min |
13.0 |
31.84 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
104667 |
2988 |
SD-Trpv1em1Sage+/+ |
mean arterial blood pressure |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion (for 0.2 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
arterial blood pressure trait |
male |
56 days-70 days |
6 |
|
|
109.0 |
mmHg |
4.0 |
9.8 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
104711 |
2988 |
SD-Trpv1em1Sage+/+ |
mean arterial blood pressure |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion (for 0.5 hours) then dihydrocapsaicin (3 mg/kg) (for 3.2 hours) then Myocardial reperfusion (for 2 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
arterial blood pressure trait |
male |
56 days-70 days |
6 |
|
|
72.0 |
mmHg |
4.0 |
9.8 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
104724 |
2988 |
SD-Trpv1em1Sage+/+ |
heart rate |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
heart pumping trait |
male |
56 days-70 days |
6 |
|
|
371.0 |
beats/min |
10.0 |
24.49 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
104747 |
2988 |
SD-Trpv1em1Sage+/+ |
heart rate |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion then dihydrocapsaicin (0.3 mg/kg) (for 0.7 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
heart pumping trait |
male |
56 days-70 days |
6 |
|
|
370.0 |
beats/min |
6.0 |
14.7 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
104748 |
2988 |
SD-Trpv1em1Sage+/+ |
heart rate |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion then V1-Cal (1 mg/kg) (for 0.7 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
heart pumping trait |
male |
56 days-70 days |
6 |
|
|
428.0 |
beats/min |
6.0 |
14.7 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
104749 |
2988 |
SD-Trpv1em1Sage+/+ |
mean arterial blood pressure |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion then cyclosporine A (2.5 mg/kg) (for 0.7 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
arterial blood pressure trait |
male |
56 days-70 days |
6 |
|
|
99.0 |
mmHg |
6.0 |
14.7 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
104756 |
2988 |
SD-Trpv1em1Sage-/- |
mean arterial blood pressure |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion then V1-Cal (1 mg/kg) (for 0.7 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
arterial blood pressure trait |
male |
56 days-70 days |
6 |
|
|
123.0 |
mmHg |
6.0 |
14.7 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
104758 |
2988 |
SD-Trpv1em1Sage-/- |
mean arterial blood pressure |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion (for 0.2 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
arterial blood pressure trait |
male |
56 days-70 days |
6 |
|
|
104.0 |
mmHg |
10.0 |
24.49 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
104781 |
2988 |
SD-Trpv1em1Sage+/+ |
mean arterial blood pressure |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion (for 0.5 hours) then cyclosporine A (2.5 mg/kg) (for 3.2 hours) then Myocardial reperfusion (for 2 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
arterial blood pressure trait |
male |
56 days-70 days |
6 |
|
|
68.0 |
mmHg |
5.0 |
12.25 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
104804 |
2988 |
SS/NEisSlc |
systolic blood pressure |
controlled cilazapril content drinking water (2.5 ug/ml) (for 547.5 days) |
Hirawa N, et al., Hypertension. 1999 Sep;34(3):496-502. |
arterial blood pressure trait |
not specified |
547 days
| 10 |
|
|
136.0 |
mmHg |
3.0 |
9.49 |
vascular indwelling catheter method |
femoral artery |
0.0 |
|
0 |
|
|
|
|
106788 |
2339 |
SS/NEisSlc |
systolic blood pressure |
controlled E4177 content drinking water (25 ug/ml) (for 547.5 days) |
Hirawa N, et al., Hypertension. 1999 Sep;34(3):496-502. |
arterial blood pressure trait |
not specified |
547 days
| 10 |
|
|
132.0 |
mmHg |
3.0 |
9.49 |
vascular indwelling catheter method |
femoral artery |
0.0 |
|
0 |
|
|
|
|
106790 |
2339 |
SHRSP/A3NCrl |
mean arterial blood pressure |
control condition |
Costell MH, etal., Front Pharmacol. 2012 Jul 5;3:128. doi: 10.3389/fphar.2012.00128. eCollection 2012. |
arterial blood pressure trait |
male |
99 days-141 days |
9 |
|
serial mean |
153.0 |
mmHg |
2.0 |
6.0 |
vascular indwelling catheter method |
femoral artery |
432000.0 |
|
0 |
|
10 seconds every 5 minutes for 24hr |
8 weeks |
baseline and after treatment |
107047 |
3073 |
SHRSP/A3NCrl |
mean arterial blood pressure |
controlled sodium chloride content drinking water (1 %) (for 56 days) and controlled fat content diet (24.5 %) (for 56 days) then controlled GSK2181236A content diet (1 mg/kg/d) (for 49 days) |
Costell MH, etal., Front Pharmacol. 2012 Jul 5;3:128. doi: 10.3389/fphar.2012.00128. eCollection 2012. |
arterial blood pressure trait |
male |
99 days-141 days |
9 |
|
serial mean |
183.0 |
mmHg |
7.0 |
21.0 |
vascular indwelling catheter method |
femoral artery |
432000.0 |
|
0 |
|
10 seconds every 5 minutes for 24hr |
high salt high fat diet +8 wk treat group |
baseline and after treatment |
107049 |
3073 |
HsdCpb:WU |
central venous pressure |
sham surgical control condition |
Szymanski MK, etal., Basic Res Cardiol. 2012 Mar;107(2):242. doi: 10.1007/s00395-011-0242-4. Epub 2012 Jan 19. |
venous blood pressure trait |
male |
84 days
| 5 |
|
|
1.2 |
mmHg |
1.9 |
4.25 |
vascular indwelling catheter method |
vena cava |
0.0 |
|
0 |
|
|
|
|
108780 |
3130 |
MWF/Hsd |
maximum rate of positive change in left ventricular blood pressure |
sham surgical control condition |
Szymanski MK, etal., Basic Res Cardiol. 2012 Mar;107(2):242. doi: 10.1007/s00395-011-0242-4. Epub 2012 Jan 19. |
heart left ventricular blood pressure trait |
male |
175 days
| 9 |
|
|
8993.0 |
mmHg/s |
318.0 |
954.0 |
vascular indwelling catheter method |
heart left ventricle |
0.0 |
|
0 |
|
|
|
|
108852 |
3130 |
HsdCpb:WU |
maximum rate of negative change in left ventricular blood pressure |
left anterior descending coronary artery occlusion |
Szymanski MK, etal., Basic Res Cardiol. 2012 Mar;107(2):242. doi: 10.1007/s00395-011-0242-4. Epub 2012 Jan 19. |
heart left ventricular blood pressure trait |
male |
175 days
| 6 |
|
|
6009.0 |
mmHg/s |
432.0 |
1058.18 |
vascular indwelling catheter method |
heart left ventricle |
0.0 |
|
0 |
|
|
|
|
108855 |
3130 |
MWF/Hsd |
heart rate |
sham surgical control condition |
Szymanski MK, etal., Basic Res Cardiol. 2012 Mar;107(2):242. doi: 10.1007/s00395-011-0242-4. Epub 2012 Jan 19. |
heart pumping trait |
male |
175 days
| 9 |
|
|
364.0 |
beats/min |
28.0 |
84.0 |
vascular indwelling catheter method |
heart |
0.0 |
|
0 |
|
|
|
|
108840 |
3130 |
MWF/Hsd |
heart rate |
left anterior descending coronary artery occlusion |
Szymanski MK, etal., Basic Res Cardiol. 2012 Mar;107(2):242. doi: 10.1007/s00395-011-0242-4. Epub 2012 Jan 19. |
heart pumping trait |
male |
175 days
| 10 |
|
|
416.0 |
beats/min |
38.0 |
120.17 |
vascular indwelling catheter method |
heart |
0.0 |
|
0 |
|
|
|
|
108841 |
3130 |
HsdCpb:WU |
left ventricular systolic blood pressure |
left anterior descending coronary artery occlusion |
Szymanski MK, etal., Basic Res Cardiol. 2012 Mar;107(2):242. doi: 10.1007/s00395-011-0242-4. Epub 2012 Jan 19. |
heart left ventricular blood pressure trait |
male |
175 days
| 6 |
|
|
123.0 |
mmHg |
8.0 |
19.6 |
vascular indwelling catheter method |
heart left ventricle |
0.0 |
|
0 |
|
|
|
|
108847 |
3130 |
MWF/Hsd |
left ventricular systolic blood pressure |
sham surgical control condition |
Szymanski MK, etal., Basic Res Cardiol. 2012 Mar;107(2):242. doi: 10.1007/s00395-011-0242-4. Epub 2012 Jan 19. |
heart left ventricular blood pressure trait |
male |
175 days
| 9 |
|
|
134.0 |
mmHg |
3.0 |
9.0 |
vascular indwelling catheter method |
heart left ventricle |
0.0 |
|
0 |
|
|
|
|
108848 |
3130 |
MWF/Hsd |
left ventricular systolic blood pressure |
left anterior descending coronary artery occlusion |
Szymanski MK, etal., Basic Res Cardiol. 2012 Mar;107(2):242. doi: 10.1007/s00395-011-0242-4. Epub 2012 Jan 19. |
heart left ventricular blood pressure trait |
male |
175 days
| 10 |
|
|
108.0 |
mmHg |
2.0 |
6.32 |
vascular indwelling catheter method |
heart left ventricle |
0.0 |
|
0 |
|
|
|
|
108849 |
3130 |
MHS |
mean arterial blood pressure |
control condition |
Capasso G, etal., Am J Physiol Renal Physiol. 2008 Aug;295(2):F556-67. doi: 10.1152/ajprenal.00340.2007. Epub 2008 May 14. |
arterial blood pressure trait |
not specified |
85 days-87 days |
11 |
|
|
167.0 |
mmHg |
1.7 |
5.64 |
vascular indwelling catheter method |
right internal carotid artery |
0.0 |
|
0 |
|
|
|
|
110141 |
3164 |
MWF |
mean arterial blood pressure |
control condition |
Schie?l IM, etal., J Pharmacol Exp Ther. 2015 May;353(2):299-306. doi: 10.1124/jpet.114.222125. Epub 2015 Feb 13. |
arterial blood pressure trait |
male |
364 days
| 5 |
|
|
144.6 |
mmHg |
6.5 |
14.53 |
vascular indwelling catheter method |
right common carotid artery plus branches |
0.0 |
|
0 |
|
|
|
|
108053 |
3113 |
SS/Hsd |
range of heart rate variation during variation of mean arterial blood pressure |
aldosterone (22.5 ng/hr) (for 14 days) and artificial cerebrospinal fluid with 0.15 M sodium (4.4-4.6 ul/hr) (for 14 days) |
Huang BS, et al., Am J Physiol Heart Circ Physiol. 2005 Feb;288(2):H517-24. doi: 10.1152/ajpheart.00651.2004. Epub 2004 Sep 30. |
heart pumping trait |
male |
52 days-61 days |
8 |
|
|
170.0 |
beats/min |
12.0 |
33.94 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
change in heart rate to change in mean arterial blood pressure ratio (range) (CMO:0003896) |
|
138433 |
2801 |
SR/Hsd |
change in heart rate to change in mean arterial blood pressure ratio |
artificial cerebrospinal fluid with 0.15 M sodium (4.4-4.6 ul/hr) (for 14 days) |
Huang BS, et al., Am J Physiol Heart Circ Physiol. 2005 Feb;288(2):H517-24. doi: 10.1152/ajpheart.00651.2004. Epub 2004 Sep 30. |
heart pumping trait |
male |
52 days-61 days |
6 |
|
|
-2.13 |
beats/min/mmHg |
0.19 |
0.47 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
change in heart rate to cchange in heart rate to change in mean arterial blood pressure ratio (CMO:0002036) |
|
138434 |
2801 |
SS/Hsd |
mean arterial pressure at the midpoint of a range of renal sympathetic nerve activity |
artificial cerebrospinal fluid with 0.15 M sodium (4.4-4.6 ul/hr) (for 14 days) |
Huang BS, et al., Am J Physiol Heart Circ Physiol. 2005 Feb;288(2):H517-24. doi: 10.1152/ajpheart.00651.2004. Epub 2004 Sep 30. |
arterial blood pressure trait |
male |
52 days-61 days |
7 |
|
|
110.0 |
mmHg |
3.0 |
7.94 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
138427 |
2801 |
SS/Hsd |
mean arterial blood pressure |
aldosterone (22.5 ng/hr) (for 14 days) and artificial cerebrospinal fluid with 0.15 M sodium (4.4-4.6 ul/hr) (for 14 days) |
Huang BS, et al., Am J Physiol Heart Circ Physiol. 2005 Feb;288(2):H517-24. doi: 10.1152/ajpheart.00651.2004. Epub 2004 Sep 30. |
arterial blood pressure trait |
male |
52 days-61 days |
0 |
|
|
125.0 |
mmHg |
2.0 |
|
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
138382 |
2801 |
SR/Hsd |
mean arterial blood pressure |
aldosterone (22.5 ng/hr) (for 14 days) and artificial cerebrospinal fluid with 0.15 M sodium (4.4-4.6 ul/hr) (for 14 days) |
Huang BS, et al., Am J Physiol Heart Circ Physiol. 2005 Feb;288(2):H517-24. doi: 10.1152/ajpheart.00651.2004. Epub 2004 Sep 30. |
arterial blood pressure trait |
male |
52 days-61 days |
0 |
|
|
105.0 |
mmHg |
3.0 |
|
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
138379 |
2801 |
SS/Hsd |
mean arterial blood pressure |
aldosterone (22.5 ng/hr) (for 14 days) and artificial cerebrospinal fluid with 0.15 M sodium (4.4-4.6 ul/hr) (for 14 days) |
Huang BS, et al., Am J Physiol Heart Circ Physiol. 2005 Feb;288(2):H517-24. doi: 10.1152/ajpheart.00651.2004. Epub 2004 Sep 30. |
arterial blood pressure trait |
male |
52 days-61 days |
0 |
|
|
131.0 |
mmHg |
3.0 |
|
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
138369 |
2801 |
SS/Hsd |
mean arterial pressure at the midpoint of a range of heart rates |
aldosterone (22.5 ng/hr) (for 14 days) and artificial cerebrospinal fluid with 0.15 M sodium (4.4-4.6 ul/hr) (for 14 days) |
Huang BS, et al., Am J Physiol Heart Circ Physiol. 2005 Feb;288(2):H517-24. doi: 10.1152/ajpheart.00651.2004. Epub 2004 Sep 30. |
arterial blood pressure trait |
male |
52 days-61 days |
8 |
|
|
132.0 |
mmHg |
3.0 |
8.49 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
138441 |
2801 |
WKY |
systolic blood pressure |
control condition |
Frantz SA, et al., Hypertension 1998 Oct;32(4):639-46 |
arterial blood pressure trait |
male |
175 days
| 24 |
|
continuous mean |
167.3 |
mmHg |
2.37 |
11.6 |
vascular indwelling catheter method |
aorta |
|
|
0 |
|
|
|
|
11901 |
206 |
HTG |
diastolic blood pressure |
control condition |
Ueno T, et al., Physiol Genomics 2004 Mar 12;17(1):38-47. |
arterial blood pressure trait |
female |
151 days-181 days |
10 |
|
|
91.8 |
mmHg |
2.8 |
8.85 |
vascular indwelling catheter method |
carotid artery and jugular vein |
|
|
0 |
|
polyethylene catheter |
|
|
11714 |
120 |
LEW |
diastolic blood pressure |
control condition |
Ueno T, et al., Physiol Genomics 2004 Mar 12;17(1):38-47. |
arterial blood pressure trait |
female |
151 days-181 days |
12 |
|
|
89.0 |
mmHg |
2.5 |
8.66 |
vascular indwelling catheter method |
carotid artery and jugular vein |
|
|
0 |
|
polyethylene catheter |
|
|
11718 |
120 |
BN/NHsdMcwi |
heart rate |
controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (between 22 and 24 days) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
heart pumping trait |
female |
92 days
| 21 |
|
serial mean |
386.5 |
beats/min |
9.6 |
43.99 |
vascular indwelling catheter method |
left femoral artery |
10800.0 |
|
0 |
|
|
|
|
69513 |
151 |
BN/NHsdMcwi |
diastolic blood pressure |
controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (between 22 and 24 days) then controlled exposure to darkness (for 12 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
89 days-91 days |
20 |
|
serial mean |
96.0 |
mmHg |
2.7 |
12.07 |
vascular indwelling catheter method |
left femoral artery |
0.0 |
|
0 |
|
|
|
|
69445 |
151 |
WKY/Izm |
mean arterial blood pressure |
control condition |
Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. |
arterial blood pressure trait |
male |
98 days
| 6 |
|
|
108.0 |
mmHg |
3.0 |
7.35 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
69083 |
1120 |
LH/MavRrrc |
absolute change in diastolic blood pressure |
losartan (20 mg/kg) (for 0.7 hours) |
Vincent M, et al., J Clin Invest 1997 Oct 15;100(8):2000-6 |
arterial blood pressure trait |
not specified |
203 days-217 days |
16 |
|
serial mean |
-5.38 |
mmHg |
1.54 |
6.17 |
vascular indwelling catheter method |
abdominal aorta |
3600 |
|
0 |
|
|
|
|
65262 |
121 |
SD-Trpv1em1Sage+/+ |
heart rate |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion (for 0.5 hours) then dihydrocapsaicin (3 mg/kg) (for 3.2 hours) then Myocardial reperfusion (for 2 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
heart pumping trait |
male |
56 days-70 days |
6 |
|
|
370.0 |
beats/min |
4.0 |
9.8 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
104706 |
2988 |
SD-Trpv1em1Sage+/+ |
heart rate |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion (for 0.5 hours) then Capsazepine (3 mg/kg) (for 3.2 hours) then Myocardial reperfusion (for 2 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
heart pumping trait |
male |
56 days-70 days |
5 |
|
|
356.0 |
beats/min |
7.0 |
15.65 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
104709 |
2988 |
SR/Hsd |
heart rate |
artificial cerebrospinal fluid with 0.15 M sodium (4.4-4.6 ul/hr) (for 14 days) |
Huang BS, et al., Am J Physiol Heart Circ Physiol. 2005 Feb;288(2):H517-24. doi: 10.1152/ajpheart.00651.2004. Epub 2004 Sep 30. |
heart pumping trait |
male |
49 days-56 days |
0 |
|
|
437.0 |
beats/min |
10.0 |
|
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
138354 |
2801 |
WKY.SHRSP-(D1Wox29-D1Arb21)/Izm |
mean arterial blood pressure |
control condition |
Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. |
arterial blood pressure trait |
male |
98 days
| 6 |
|
|
103.0 |
mmHg |
2.0 |
4.9 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
84551 |
1120 |
WKY.SHRSP-(D1Wox29-D1Arb21)/Izm |
absolute change in mean arterial blood pressure |
air-jet exposure (for 0 hours) then candesartan (1 ug) (for 0 hours) |
Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. |
arterial blood pressure trait |
male |
98 days
| 6 |
|
|
-2.0 |
mmHg |
3.0 |
7.35 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
84554 |
1120 |
WKY.SHRSP-(D1Wox29-D1Arb21)/Izm |
heart rate |
control condition |
Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. |
heart pumping trait |
male |
98 days
| 6 |
|
|
326.0 |
beats/min |
12.0 |
29.39 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
84560 |
1120 |
MW |
mean arterial blood pressure |
unilateral nephrectomy (for 70 days) then puromycin aminonucleoside (100 mg/kg) then puromycin aminonucleoside (40 mg/kg) |
Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. |
arterial blood pressure trait |
male |
0 days
| 6 |
undefined |
|
105.0 |
mmHg |
2.0 |
4.9 |
vascular indwelling catheter method |
|
0.0 |
unx |
70 |
days |
|
|
|
101172 |
2581 |
SS/JrHsdMcwi |
diastolic blood pressure |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
92 days-94 days |
12 |
|
serial mean |
126.0 |
mmHg |
5.0 |
17.32 |
vascular indwelling catheter method |
left femoral artery |
0 |
|
0 |
|
|
|
|
65465 |
151 |
BN/NHsdMcwi |
mean arterial blood pressure |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
92 days-94 days |
14 |
|
serial mean |
89.0 |
mmHg |
2.0 |
7.48 |
vascular indwelling catheter method |
left femoral artery |
0 |
|
0 |
|
|
|
|
65466 |
151 |
SHR.BN-(D2Rat114-D2Rat123)/Jk |
systolic blood pressure |
controlled sodium content drinking water (1 %) (for 15 days) |
Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6. |
arterial blood pressure trait |
male |
99 days
| 23 |
|
continuous mean |
179.3 |
mmHg |
3.5 |
16.79 |
vascular indwelling catheter method |
femoral artery |
1800 |
|
0 |
|
pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH) |
|
|
12750 |
306 |
WKY/Gcrc |
systolic blood pressure |
controlled sodium content drinking water (1 %) (for 21 days) |
Graham D, et al., Hypertension. 2007 Dec; 50(6):1134-41. |
arterial blood pressure trait |
male |
126 days-147 days |
10 |
|
|
146.4 |
mmHg |
2.53 |
8.0 |
vascular indwelling catheter method |
abdominal aorta |
1814400 |
|
0 |
|
implanted at 84 days with 7 day recovery; Dataquest IV telemetry system (Data Sciences International) |
averaged over 21 days |
|
12727 |
302 |
BN.GH-(D18Rat41-D18Mgh4)/Mcwi |
systolic blood pressure |
control condition |
Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. |
arterial blood pressure trait |
male |
127 days-143 days |
21 |
|
serial mean |
116.7 |
mmHg |
1.51 |
6.9 |
vascular indwelling catheter method |
left femoral artery and vein |
4 hrs/day for 3 days |
|
0 |
|
microrenathane catheter; recover for 1 week after surgery |
|
|
11543 |
101 |
SS/JrHsdMcwi |
systolic blood pressure |
controlled sodium content diet (0.1 %) (for 28 days) then controlled sodium content diet (8 %) (for 31 days) and controlled exposure to ambient light (for 12 hours) |
Cowley AW Jr, et al., Physiol Genomics 2000 Apr 27;2(3):107-15. |
arterial blood pressure trait |
male |
91 days-94 days |
35 |
|
continuous mean |
206.0 |
mmHg |
6.0 |
35.5 |
vascular indwelling catheter method |
femoral artery |
259200.0 |
|
0 |
|
3 h per day |
|
|
11984 |
229 |
LH/MavRrrc |
systolic blood pressure |
control condition |
Vincent M, et al., J Clin Invest 1997 Oct 15;100(8):2000-6 |
arterial blood pressure trait |
not specified |
203 days-217 days |
17 |
|
serial mean |
173.0 |
mmHg |
2.18 |
9.0 |
vascular indwelling catheter method |
abdominal aorta |
3600 |
|
0 |
|
|
|
|
11720 |
121 |
MHS/Gib |
systolic blood pressure |
control condition |
Zagato et al., 2000, Hypertension, 36(5), 734-9 |
arterial blood pressure trait |
not specified |
112 days
| 22 |
|
continuous mean |
163.7 |
mmHg |
1.9 |
8.91 |
vascular indwelling catheter method |
carotid artery |
1 min tracing every 3-4 min for 1 h |
|
0 |
|
Gould BS3200 BP recorder |
|
|
11726 |
122 |
SS/JrHsdMcwi |
diastolic blood pressure |
controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (between 22 and 24 days) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
89 days-92 days |
21 |
|
serial mean |
154.0 |
mmHg |
6.0 |
27.5 |
vascular indwelling catheter method |
left femoral artery |
|
|
0 |
|
3 hrs (during inactive phase) 3 consecutive days, and 4 extra hrs (during active phase) next day |
|
|
11852 |
151 |
SS/JrHsdMcwi |
mean arterial blood pressure |
controlled sodium content diet (0.1 %) (for 28 days) then controlled sodium content diet (8 %) (for 31 days) and controlled exposure to ambient light (for 12 hours) |
Cowley AW Jr, et al., Physiol Genomics 2000 Apr 27;2(3):107-15. |
arterial blood pressure trait |
male |
91 days-94 days |
35 |
|
continuous mean |
185.0 |
mmHg |
5.0 |
29.58 |
vascular indwelling catheter method |
femoral artery |
259200.0 |
|
0 |
|
3 h per day |
|
|
12004 |
229 |
SS/JrHsdMcwi |
mean arterial blood pressure |
controlled sodium content diet (0.1 %) (for 28 days) then controlled sodium content diet (8 %) (for 30 days) and controlled exposure to darkness (for 12 hours) |
Cowley AW Jr, et al., Physiol Genomics 2000 Apr 27;2(3):107-15. |
arterial blood pressure trait |
male |
91 days-93 days |
35 |
|
continuous mean |
172.0 |
mmHg |
7.0 |
41.41 |
vascular indwelling catheter method |
femoral artery |
14400.0 |
|
0 |
|
left femoral artery |
|
|
12005 |
229 |
BN/NHsdMcwi |
diastolic blood pressure |
controlled sodium content diet (0.1 %) (for 28 days) then controlled sodium content diet (8 %) (for 31 days) and controlled exposure to ambient light (for 12 hours) |
Cowley AW Jr, et al., Physiol Genomics 2000 Apr 27;2(3):107-15. |
arterial blood pressure trait |
male |
91 days-94 days |
42 |
|
continuous mean |
94.0 |
mmHg |
2.0 |
12.96 |
vascular indwelling catheter method |
femoral artery |
259200.0 |
|
0 |
|
3 h per day |
|
|
12009 |
229 |
LH/MavRrrc |
absolute change in systolic blood pressure |
darodipine (200 ug/kg) (for 0.2 hours) |
Vincent M, et al., J Clin Invest 1997 Oct 15;100(8):2000-6 |
arterial blood pressure trait |
not specified |
203 days-217 days |
16 |
|
serial mean |
-97.8 |
mmHg |
2.7 |
10.8 |
vascular indwelling catheter method |
abdominal aorta |
3600 |
|
0 |
|
|
|
|
65268 |
121 |
BN/NHsdMcwi |
mean arterial blood pressure |
controlled sodium content diet (0.4 %) (for 28 days) then controlled sodium content diet (8 %) (for 30 days) and controlled exposure to ambient light (for 12 hours) |
Cowley AW Jr, et al., Physiol Genomics 2000 Apr 27;2(3):107-15. |
arterial blood pressure trait |
male |
91 days-93 days |
42 |
|
continuous mean |
109.0 |
mmHg |
3.0 |
19.44 |
vascular indwelling catheter method |
femoral artery |
259200.0 |
|
0 |
|
3 h per day |
increase |
|
66139 |
229 |
BN/NHsdMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) then tactile electric shock exposure (2 %) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
92 days-94 days |
14 |
|
serial mean |
16.0 |
mmHg |
3.0 |
11.22 |
vascular indwelling catheter method |
left femoral artery |
0 |
|
0 |
|
|
|
|
66149 |
151 |
BN |
systolic blood pressure |
controlled sodium content drinking water (1 %) (for 15 days) |
Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6. |
arterial blood pressure trait |
male |
99 days
| 64 |
|
continuous mean |
134.4 |
mmHg |
8.7 |
69.6 |
vascular indwelling catheter method |
femoral artery |
1800 |
|
0 |
|
pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH) |
|
|
65342 |
306 |
SHR.WKY-(D1Wox19-D1Wox34)/Njs |
systolic blood pressure |
control condition |
Frantz S, et al., Hypertension 2001 Aug;38(2):216-21 |
arterial blood pressure trait |
male |
196 days
| 20 |
|
|
187.5 |
mmHg |
2.73 |
12.2 |
vascular indwelling catheter method |
|
|
|
0 |
|
beat to beat for 1 hour |
|
|
11329 |
72 |
WKY/NCruk |
diastolic blood pressure |
control condition |
Frantz S, et al., Hypertension 2001 Aug;38(2):216-21 |
arterial blood pressure trait |
male |
196 days
| 19 |
|
|
95.8 |
mmHg |
2.2 |
9.6 |
vascular indwelling catheter method |
|
|
|
0 |
|
beat to beat for 1 hour |
|
|
11332 |
72 |
WKY.SHR-(D1Wox19-D1Mit2)/Njs |
diastolic blood pressure |
control condition |
Frantz S, et al., Hypertension 2001 Aug;38(2):216-21 |
arterial blood pressure trait |
male |
196 days
| 20 |
|
|
116.3 |
mmHg |
2.24 |
10.0 |
vascular indwelling catheter method |
|
|
|
0 |
|
beat to beat for 1 hour |
|
|
11333 |
72 |
SHR/NCruk |
diastolic blood pressure |
control condition |
Frantz S, et al., Hypertension 2001 Aug;38(2):216-21 |
arterial blood pressure trait |
male |
196 days
| 15 |
|
|
147.8 |
mmHg |
3.18 |
12.3 |
vascular indwelling catheter method |
|
|
|
0 |
|
beat to beat for 1 hour |
|
|
11336 |
72 |
WKY/Bbb |
heart rate |
control condition |
Kreutz R, et al., Circulation 1997 Aug 19;96(4):1078-81. |
heart pumping trait |
male |
112 days
| 12 |
|
serial mean |
343.0 |
beats/min |
10.1 |
35.0 |
vascular indwelling catheter method |
femoral artery |
|
|
0 |
|
|
3 sets of readings per day for two days |
|
13279 |
334 |
WKY/Bbb |
heart rate |
controlled sodium content drinking water (1 %) (between 13 and 15 days) |
Kreutz R, et al., Circulation 1997 Aug 19;96(4):1078-81. |
heart pumping trait |
male |
125 days-127 days |
11 |
|
serial mean |
349.0 |
beats/min |
12.06 |
40.0 |
vascular indwelling catheter method |
femoral artery |
|
|
0 |
|
|
3 sets of readings per day for two days |
|
13286 |
334 |
SHRSP/Bbb |
heart rate |
controlled sodium content drinking water (1 %) (between 13 and 15 days) |
Kreutz R, et al., Circulation 1997 Aug 19;96(4):1078-81. |
heart pumping trait |
female |
125 days-127 days |
10 |
|
serial mean |
442.0 |
beats/min |
9.17 |
29.0 |
vascular indwelling catheter method |
femoral artery |
|
|
0 |
|
|
3 sets of readings per day for two days |
|
13291 |
334 |
LEW/Cub |
diastolic blood pressure |
losartan (10 mg/kg) (for 0.2 hours) then pentolinium (5 mg/kg) (for 0.1 hours) then NG-nitroarginine methyl ester (30 mg/kg) (for 0.3 hours) |
Ueno T, et al., Physiol Res 2003;52(6):689-700. |
arterial blood pressure trait |
not specified |
0 days
| 9 |
|
continuous mean |
82.5 |
mmHg |
|
|
vascular indwelling catheter method |
|
|
|
0 |
|
|
|
|
65392 |
568 |
SHR.BN-(D2Rat114-D2Rat123)/Jk |
systolic blood pressure |
control condition |
Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6. |
arterial blood pressure trait |
male |
99 days
| 22 |
|
continuous mean |
175.0 |
mmHg |
2.0 |
9.38 |
vascular indwelling catheter method |
femoral artery |
1800 |
|
0 |
|
pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH) |
|
|
65393 |
306 |
SHR.BN-(D2Rat114-D2Rat123)/Jk |
mean arterial blood pressure |
control condition |
Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6. |
arterial blood pressure trait |
male |
99 days
| 22 |
|
continuous mean |
151.0 |
mmHg |
2.0 |
9.38 |
vascular indwelling catheter method |
femoral artery |
1800 |
|
0 |
|
pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH) |
|
|
65394 |
306 |
SHR.BN-(D4Rat33-D4Rat54)/Jk |
diastolic blood pressure |
control condition |
Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6. |
arterial blood pressure trait |
male |
99 days
| 22 |
|
continuous mean |
125.0 |
mmHg |
2.0 |
9.38 |
vascular indwelling catheter method |
femoral artery |
1800 |
|
0 |
|
pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH) |
|
|
65405 |
306 |
SHR.BN-(D4Rat33-D4Rat54)/Jk |
mean arterial blood pressure |
control condition |
Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6. |
arterial blood pressure trait |
male |
99 days
| 22 |
|
continuous mean |
149.0 |
mmHg |
2.0 |
9.38 |
vascular indwelling catheter method |
femoral artery |
1800 |
|
0 |
|
pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH) |
|
|
65407 |
306 |
SHR.BN-(D16Rat87-D16Mgh1)/Jk |
diastolic blood pressure |
control condition |
Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6. |
arterial blood pressure trait |
male |
99 days
| 22 |
|
continuous mean |
135.0 |
mmHg |
2.0 |
9.38 |
vascular indwelling catheter method |
femoral artery |
1800 |
|
0 |
|
pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH) |
|
|
65410 |
306 |
SHR.BN-(D16Rat87-D16Mgh1)/Jk |
mean arterial blood pressure |
control condition |
Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6. |
arterial blood pressure trait |
male |
99 days
| 22 |
|
continuous mean |
158.0 |
mmHg |
2.0 |
9.38 |
vascular indwelling catheter method |
femoral artery |
1800 |
|
0 |
|
pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH) |
|
|
65412 |
306 |
SHR.BN-(D2Rat114-D2Rat123)/Jk |
heart rate |
control condition (for 98 days) |
Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6. |
heart pumping trait |
male |
87 days
| 22 |
|
continuous mean |
362.0 |
beats/min |
5.0 |
23.45 |
vascular indwelling catheter method |
femoral artery |
1800 |
|
0 |
|
pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH) |
|
|
65417 |
306 |
SHR.BN-(D4Rat33-D4Rat54)/Jk |
heart rate |
controlled sodium content diet (1 %) (for 14 days) |
Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6. |
heart pumping trait |
male |
87 days
| 23 |
|
continuous mean |
363.0 |
beats/min |
5.0 |
23.98 |
vascular indwelling catheter method |
femoral artery |
1800 |
|
0 |
|
pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH) |
|
|
65423 |
306 |
SHR/Ola |
systolic blood pressure |
control condition |
Pravenec M, et al., J Hypertens 1989 Mar;7(3):217-21. |
arterial blood pressure trait |
male |
0 days
| 29 |
|
|
214.0 |
mmHg |
4.0 |
21.54 |
vascular indwelling catheter method |
carotid artery segment |
|
|
0 |
|
|
|
|
66034 |
651 |
BN-Lx/Cub |
systolic blood pressure |
control condition |
Pravenec M, et al., J Hypertens 1989 Mar;7(3):217-21. |
arterial blood pressure trait |
male |
0 days
| 8 |
|
|
132.0 |
mmHg |
3.0 |
8.49 |
vascular indwelling catheter method |
carotid artery segment |
|
|
0 |
|
|
|
|
66035 |
651 |
WKY/NCruk |
mean arterial blood pressure |
air oxygen content (10 %) (for 21 days) |
Zhao L et al., 2001, Circulation, 103(3), 442-7 |
arterial blood pressure trait |
male |
105 days
| 28 |
|
median |
78.0 |
mmHg |
|
|
vascular indwelling catheter method |
left common carotid artery |
0 |
|
0 |
|
|
|
|
66130 |
102 |
GH/Omr |
change in mean arterial blood pressure to change in vasoactive chemical dose ratio |
angiotensin II (5-50 ng/kg/min) (between 0.2 and 1 hours) |
Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. |
arterial blood pressure trait |
male |
130 days-144 days |
14 |
|
|
0.48 |
mmHg/ng/kg/min |
0.02 |
0.08 |
vascular indwelling catheter method |
left femoral artery and vein |
0.0 |
|
0 |
|
microrenathane catheter; recover for 1 week after surgery |
slope of map response curve |
|
68339 |
101 |
WKY.WKHA-(D5Rat45-D5Rat245)/Cfd |
left ventricular end-diastolic blood pressure |
sham surgical control condition |
Souzeau E, et al., Hypertension. 2006 Jan;47(1):128-33. Epub 2005 Dec 12. |
heart left ventricular blood pressure trait |
male |
84 days-154 days |
5 |
|
|
0.52 |
mmHg |
0.27 |
0.6 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
68806 |
1014 |
BN/NHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101 days-103 days |
21 |
|
serial mean |
111.8 |
mmHg |
3.9 |
17.87 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
0 |
|
|
|
|
69527 |
151 |
SS/JrHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then angiotensin II (20 ng/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101 days-103 days |
13 |
|
serial mean |
131.3 |
mmHg |
4.2 |
15.14 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
0 |
|
|
|
|
69530 |
151 |
SS/JrHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then angiotensin II (100 ng/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101 days-103 days |
13 |
|
serial mean |
147.2 |
mmHg |
3.9 |
14.06 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
0 |
|
|
|
|
69532 |
151 |
SS/JrHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then norepinephrine (3 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101 days-103 days |
13 |
|
serial mean |
168.4 |
mmHg |
7.0 |
25.24 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
0 |
|
|
|
|
69540 |
151 |
SS/JrHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then acetylcholine (0.2 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101 days-103 days |
9 |
|
serial mean |
134.7 |
mmHg |
7.4 |
22.2 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
0 |
|
|
|
|
69544 |
151 |
BN/NHsdMcwi |
diastolic blood pressure |
controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (between 22 and 24 days) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
92 days
| 20 |
|
serial mean |
103.2 |
mmHg |
2.8 |
12.52 |
vascular indwelling catheter method |
left femoral artery |
10800.0 |
|
0 |
|
|
|
|
69511 |
151 |
SS/JrHsdMcwi |
diastolic blood pressure |
controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (between 22 and 24 days) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
92 days
| 16 |
|
serial mean |
163.0 |
mmHg |
6.4 |
25.6 |
vascular indwelling catheter method |
left femoral artery |
10800.0 |
|
0 |
|
|
|
|
69512 |
151 |
SS/JrHsdMcwi |
heart rate |
controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (between 22 and 24 days) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
heart pumping trait |
female |
92 days
| 21 |
|
serial mean |
425.4 |
beats/min |
10.5 |
48.12 |
vascular indwelling catheter method |
left femoral artery |
10800.0 |
|
0 |
|
|
|
|
69514 |
151 |
BN/NHsdMcwi |
diastolic blood pressure |
controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (between 22 and 24 days) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
93 days
| 21 |
|
serial mean |
89.6 |
mmHg |
2.5 |
11.46 |
vascular indwelling catheter method |
left femoral artery |
10800.0 |
|
0 |
|
|
|
|
69517 |
151 |
WKY.WKHA-(D5Rat45-D5Rat245)/Cfd |
left ventricular end-diastolic blood pressure |
sham surgical control condition |
Souzeau E, et al., Hypertension. 2006 Jan;47(1):128-33. Epub 2005 Dec 12. |
heart left ventricular blood pressure trait |
female |
84 days-154 days |
5 |
|
|
0.22 |
mmHg |
0.25 |
0.56 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
68859 |
1014 |
WKHA/Cfd |
left ventricular end-systolic blood pressure |
artificial aortocaval fistula |
Souzeau E, et al., Hypertension. 2006 Jan;47(1):128-33. Epub 2005 Dec 12. |
heart left ventricular blood pressure trait |
male |
84 days-154 days |
5 |
|
|
135.0 |
mmHg |
1.71 |
3.82 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
68864 |
1014 |
WKHA/Cfd |
left ventricular end-systolic blood pressure |
sham surgical control condition |
Souzeau E, et al., Hypertension. 2006 Jan;47(1):128-33. Epub 2005 Dec 12. |
heart left ventricular blood pressure trait |
female |
84 days-154 days |
5 |
|
|
131.0 |
mmHg |
5.0 |
11.18 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
68869 |
1014 |
WKY/Cfd |
maximum rate of positive change in left ventricular blood pressure |
artificial aortocaval fistula |
Souzeau E, et al., Hypertension. 2006 Jan;47(1):128-33. Epub 2005 Dec 12. |
heart left ventricular blood pressure trait |
male |
84 days-154 days |
5 |
|
|
8304.0 |
mmHg/s |
596.0 |
1332.7 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
68891 |
1014 |
WKY/Cfd |
maximum rate of negative change in left ventricular blood pressure |
sham surgical control condition |
Souzeau E, et al., Hypertension. 2006 Jan;47(1):128-33. Epub 2005 Dec 12. |
heart left ventricular blood pressure trait |
male |
84 days-154 days |
5 |
|
|
6808.0 |
mmHg/s |
588.0 |
1314.81 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
"rate of maximum negative change in left ventricular blood pressure" mmHg/s |
|
68902 |
1014 |
WKHA/Cfd |
maximum rate of negative change in left ventricular blood pressure |
sham surgical control condition |
Souzeau E, et al., Hypertension. 2006 Jan;47(1):128-33. Epub 2005 Dec 12. |
heart left ventricular blood pressure trait |
male |
84 days-154 days |
5 |
|
|
5901.0 |
mmHg/s |
507.0 |
1133.69 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
68904 |
1014 |
WKHA/Cfd |
maximum rate of negative change in left ventricular blood pressure |
artificial aortocaval fistula |
Souzeau E, et al., Hypertension. 2006 Jan;47(1):128-33. Epub 2005 Dec 12. |
heart left ventricular blood pressure trait |
male |
84 days-154 days |
5 |
|
|
6859.0 |
mmHg/s |
460.0 |
1028.59 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
68905 |
1014 |
WKHA/Cfd |
maximum rate of negative change in left ventricular blood pressure |
sham surgical control condition |
Souzeau E, et al., Hypertension. 2006 Jan;47(1):128-33. Epub 2005 Dec 12. |
heart left ventricular blood pressure trait |
female |
84 days-154 days |
5 |
|
|
6612.0 |
mmHg/s |
308.0 |
688.71 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
68910 |
1014 |
WKY.SHR-(D1Mgh14-D1Rat77)/Iwai |
diastolic blood pressure |
controlled sodium content diet (8 %) (for 14 days) then controlled exposure to darkness (for 12 hours) |
Iwai N, et al., Circulation 1999 Nov 2;100(18):1923-9. |
arterial blood pressure trait |
male |
126 days
| 8 |
|
|
96.8 |
mmHg |
0.88 |
2.5 |
vascular indwelling catheter method |
left common carotid artery |
0.0 |
|
0 |
|
|
nighttime (7 PM - 7 AM) |
|
70096 |
1281 |
WKY/NCrl |
diastolic blood pressure |
controlled exposure to ambient light (for 12 hours) |
Iwai N, et al., Circulation 1999 Nov 2;100(18):1923-9. |
arterial blood pressure trait |
male |
112 days
| 7 |
|
|
88.7 |
mmHg |
0.83 |
2.2 |
vascular indwelling catheter method |
left common carotid artery |
0.0 |
|
0 |
|
|
daytime (7 AM - 7 PM) |
|
70083 |
1281 |
WKY.SHR-(D1Mgh14-D1Rat77)/Iwai |
systolic blood pressure |
controlled exposure to ambient light (for 12 hours) |
Iwai N, et al., Circulation 1999 Nov 2;100(18):1923-9. |
arterial blood pressure trait |
male |
112 days
| 8 |
|
|
125.5 |
mmHg |
0.57 |
1.6 |
vascular indwelling catheter method |
left common carotid artery |
0.0 |
|
0 |
|
|
daytime (7 AM - 7 PM) |
|
70089 |
1281 |
WKY.SHR-(D1Mgh14-D1Rat77)/Iwai |
systolic blood pressure |
controlled sodium content diet (8 %) (for 14 days) then controlled exposure to darkness (for 12 hours) |
Iwai N, et al., Circulation 1999 Nov 2;100(18):1923-9. |
arterial blood pressure trait |
male |
126 days
| 8 |
|
|
136.2 |
mmHg |
1.03 |
2.9 |
vascular indwelling catheter method |
left common carotid artery |
0.0 |
|
0 |
|
|
nighttime (7 PM - 7 AM) |
|
70094 |
1281 |
WKY/Izm |
absolute change in mean arterial blood pressure |
air-jet exposure (for 0 hours) |
Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. |
arterial blood pressure trait |
male |
98 days
| 6 |
|
|
22.0 |
mmHg |
2.0 |
4.9 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
84537 |
1120 |
WKY.SHRSP-(D1Wox29-D1Arb21)/Izm |
absolute change in mean arterial blood pressure |
air-jet exposure (for 0 hours) |
Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. |
arterial blood pressure trait |
male |
98 days
| 6 |
|
|
35.0 |
mmHg |
3.0 |
7.35 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
84538 |
1120 |
WKY/Izm |
absolute change in mean arterial blood pressure |
candesartan (1 ug) (for 0 hours) then air-jet exposure (for 0 hours) then angiotensin II (20 ng) |
Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. |
arterial blood pressure trait |
male |
98 days
| 6 |
|
|
0.0 |
mmHg |
1.0 |
2.45 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
84567 |
1120 |
WKY/Izm |
absolute change in mean arterial blood pressure |
candesartan (1 ug) (for 0 hours) then air-jet exposure (for 0 hours) then angiotensin II (20 ng) then phenylephrine (3 ug) |
Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. |
arterial blood pressure trait |
male |
98 days
| 6 |
|
|
53.0 |
mmHg |
3.0 |
7.35 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
84571 |
1120 |
WKY.SHRSP-(D1Wox29-D1Arb21)/Izm |
absolute change in mean arterial blood pressure |
vehicle control condition (2 ul) (for 0 hours) then air-jet exposure (for 0 hours) then angiotensin II (20 ng) then phenylephrine (3 ug) |
Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. |
arterial blood pressure trait |
male |
98 days
| 6 |
|
|
50.0 |
mmHg |
3.0 |
7.35 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
84572 |
1120 |
WKY.SHRSP-(D1Wox29-D1Arb21)/Izm |
heart rate |
control condition |
Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. |
heart pumping trait |
male |
98 days
| 6 |
|
|
329.0 |
beats/min |
13.0 |
31.84 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
84561 |
1120 |
WKY/Izm |
absolute change in heart rate |
air-jet exposure (for 0 hours) then candesartan (1 ug) (for 0 hours) |
Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. |
heart pumping trait |
male |
98 days
| 6 |
|
|
-5.0 |
beats/min |
11.0 |
26.94 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
84563 |
1120 |
WKY/Izm |
mean arterial blood pressure |
control condition |
Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. |
arterial blood pressure trait |
male |
98 days
| 6 |
|
|
107.0 |
mmHg |
4.0 |
9.8 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
84547 |
1120 |
MW |
mean arterial blood pressure |
nephrectomy (for 28 days) then reserpine (5 mg/l) (for 21 days) and hydralazine (80 mg/l) (for 21 days) and controlled hydralazine content drinking water (25 mg/l) (for 21 days) |
Anderson S, et al., J Clin Invest. 1986 Jun;77(6):1993-2000. |
arterial blood pressure trait |
male |
0 days
| 8 |
undefined |
|
107.0 |
mmHg |
3.0 |
8.49 |
vascular indwelling catheter method |
|
0.0 |
5/6 nephrectomy |
28 |
days |
|
|
|
100997 |
2561 |
MW |
mean arterial blood pressure |
unilateral nephrectomy (for 70 days) then vehicle control condition |
Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. |
arterial blood pressure trait |
male |
0 days
| 7 |
undefined |
|
108.0 |
mmHg |
2.0 |
5.29 |
vascular indwelling catheter method |
|
0.0 |
unx |
70 |
days |
|
|
|
101173 |
2581 |
SS/JrIpcv |
diastolic blood pressure |
controlled sodium content diet (0.3 %) |
Hojn¿ S, et al., Physiol Res. 2005;54(2):201-6. |
arterial blood pressure trait |
male |
0 days
| 0 |
undefined |
|
108.0 |
mmHg |
3.0 |
|
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
102400 |
2688 |
SD-Trpv1em1Sage+/+ |
heart rate |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion (for 0.2 hours) then cyclosporine A (2.5 mg/kg) (for 0.9 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
heart pumping trait |
male |
56 days-70 days |
6 |
|
|
398.0 |
beats/min |
16.0 |
39.19 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
104774 |
2988 |
SD-Trpv1em1Sage+/+ |
mean arterial blood pressure |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion (for 0.2 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
arterial blood pressure trait |
male |
56 days-70 days |
6 |
|
|
103.0 |
mmHg |
12.0 |
29.39 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
104777 |
2988 |
SD-Trpv1em1Sage+/+ |
mean arterial blood pressure |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion (for 0.5 hours) then Myocardial reperfusion (for 2 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
arterial blood pressure trait |
male |
56 days-70 days |
6 |
|
|
92.0 |
mmHg |
6.0 |
14.7 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
104801 |
2988 |
SD-Trpv1em1Sage+/+ |
mean arterial blood pressure |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
arterial blood pressure trait |
male |
56 days-70 days |
6 |
|
|
127.0 |
mmHg |
4.0 |
9.8 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
104675 |
2988 |
SD-Trpv1em1Sage+/+ |
heart rate |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion (for 0.2 hours) then dihydrocapsaicin (3 mg/kg) (for 0.9 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
heart pumping trait |
male |
56 days-70 days |
6 |
|
|
420.0 |
beats/min |
9.0 |
22.05 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
104697 |
2988 |
SD-Trpv1em1Sage+/+ |
heart rate |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion (for 0.5 hours) then Myocardial reperfusion (for 2 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
heart pumping trait |
male |
56 days-70 days |
6 |
|
|
350.0 |
beats/min |
8.0 |
19.6 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
104702 |
2988 |
SD-Trpv1em1Sage+/+ |
mean arterial blood pressure |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion (for 0.2 hours) then cyclosporine A (2.5 mg/kg) (for 0.9 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
arterial blood pressure trait |
male |
56 days-70 days |
6 |
|
|
89.0 |
mmHg |
4.0 |
9.8 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
104719 |
2988 |
SD-Trpv1em1Sage+/+ |
mean arterial blood pressure |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion (for 0.5 hours) then Capsazepine (3 mg/kg) (for 3.2 hours) then Myocardial reperfusion (for 2 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
arterial blood pressure trait |
male |
56 days-70 days |
5 |
|
|
89.0 |
mmHg |
3.0 |
6.71 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
104727 |
2988 |
SD-Trpv1em1Sage+/+ |
mean arterial blood pressure |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
arterial blood pressure trait |
male |
56 days-70 days |
6 |
|
|
118.0 |
mmHg |
7.0 |
17.15 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
104753 |
2988 |
SHRSP/A3NCrl |
mean arterial blood pressure |
controlled sodium chloride content drinking water (1 %) (for 56 days) and controlled fat content diet (24.5 %) (for 56 days) |
Costell MH, etal., Front Pharmacol. 2012 Jul 5;3:128. doi: 10.3389/fphar.2012.00128. eCollection 2012. |
arterial blood pressure trait |
male |
99 days-141 days |
9 |
|
serial mean |
192.0 |
mmHg |
10.0 |
30.0 |
vascular indwelling catheter method |
femoral artery |
432000.0 |
|
0 |
|
10 seconds every 5 minutes for 24hr |
high salt high fat diet group |
baseline and after treatment |
107048 |
3073 |
HsdCpb:WU |
left ventricular end-diastolic blood pressure |
sham surgical control condition |
Szymanski MK, etal., Basic Res Cardiol. 2012 Mar;107(2):242. doi: 10.1007/s00395-011-0242-4. Epub 2012 Jan 19. |
heart left ventricular blood pressure trait |
male |
84 days
| 5 |
|
|
5.3 |
mmHg |
2.4 |
5.37 |
vascular indwelling catheter method |
heart left ventricle |
0.0 |
|
0 |
|
|
|
|
108776 |
3130 |
HsdCpb:WU |
maximum rate of positive change in left ventricular blood pressure |
left anterior descending coronary artery occlusion |
Szymanski MK, etal., Basic Res Cardiol. 2012 Mar;107(2):242. doi: 10.1007/s00395-011-0242-4. Epub 2012 Jan 19. |
heart left ventricular blood pressure trait |
male |
175 days
| 6 |
|
|
7463.0 |
mmHg/s |
375.0 |
918.56 |
vascular indwelling catheter method |
heart left ventricle |
0.0 |
|
0 |
|
|
|
|
108851 |
3130 |
MWF/Hsd |
systemic vascular resistance |
sham surgical control condition |
Szymanski MK, etal., Basic Res Cardiol. 2012 Mar;107(2):242. doi: 10.1007/s00395-011-0242-4. Epub 2012 Jan 19. |
arterial blood pressure trait |
male |
168 days
| 9 |
|
|
0.81 |
mmHg/ml/min |
0.07 |
0.21 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
108892 |
3130 |
MWF/Hsd |
renal vascular resistance |
sham surgical control condition |
Szymanski MK, etal., Basic Res Cardiol. 2012 Mar;107(2):242. doi: 10.1007/s00395-011-0242-4. Epub 2012 Jan 19. |
arterial blood pressure trait |
male |
175 days
| 9 |
|
|
52.8 |
mmHg/ml/min |
13.1 |
39.3 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
108895 |
3130 |
SS/Hsd |
heart rate |
aldosterone (22.5 ng/hr) (for 14 days) and artificial cerebrospinal fluid with 0.15 M sodium (4.4-4.6 ul/hr) (for 14 days) |
Huang BS, et al., Am J Physiol Heart Circ Physiol. 2005 Feb;288(2):H517-24. doi: 10.1152/ajpheart.00651.2004. Epub 2004 Sep 30. |
heart pumping trait |
male |
49 days-56 days |
0 |
|
|
513.0 |
beats/min |
19.0 |
|
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
138357 |
2801 |
SR/Hsd |
mean arterial blood pressure |
artificial cerebrospinal fluid with 0.15 M sodium (4.4-4.6 ul/hr) (for 14 days) |
Huang BS, et al., Am J Physiol Heart Circ Physiol. 2005 Feb;288(2):H517-24. doi: 10.1152/ajpheart.00651.2004. Epub 2004 Sep 30. |
arterial blood pressure trait |
male |
52 days-61 days |
0 |
|
|
107.0 |
mmHg |
2.0 |
|
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
138366 |
2801 |
SS/Hsd |
percent change in mean arterial blood pressure |
artificial cerebrospinal fluid with 0.15 M sodium (4.4-4.6 ul/hr) (for 14 days) then air-jet exposure (1-1.5 lb/in2) (for 0 hours) |
Huang BS, et al., Am J Physiol Heart Circ Physiol. 2005 Feb;288(2):H517-24. doi: 10.1152/ajpheart.00651.2004. Epub 2004 Sep 30. |
arterial blood pressure trait |
male |
52 days-61 days |
0 |
|
|
8.0 |
% |
2.0 |
|
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
138372 |
2801 |
SS/Hsd |
percent change in mean arterial blood pressure |
aldosterone (22.5 ng/hr) (for 14 days) then air-jet exposure (1-1.5 lb/in2) (for 0 hours) |
Huang BS, et al., Am J Physiol Heart Circ Physiol. 2005 Feb;288(2):H517-24. doi: 10.1152/ajpheart.00651.2004. Epub 2004 Sep 30. |
arterial blood pressure trait |
male |
52 days-61 days |
0 |
|
|
19.0 |
% |
3.0 |
|
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
138373 |
2801 |
SS/Hsd |
mean arterial pressure at the midpoint of a range of heart rates |
artificial cerebrospinal fluid with 0.15 M sodium (4.4-4.6 ul/hr) (for 14 days) |
Huang BS, et al., Am J Physiol Heart Circ Physiol. 2005 Feb;288(2):H517-24. doi: 10.1152/ajpheart.00651.2004. Epub 2004 Sep 30. |
arterial blood pressure trait |
male |
52 days-61 days |
7 |
|
|
110.0 |
mmHg |
2.0 |
5.29 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
138440 |
2801 |
SS/Hsd |
mean arterial blood pressure |
aldosterone (22.5 ng/hr) (for 14 days) and artificial cerebrospinal fluid with 0.14 M sodium (4.4-4.6 ul/hr) (for 14 days) |
Huang BS, et al., Am J Physiol Heart Circ Physiol. 2005 Feb;288(2):H517-24. doi: 10.1152/ajpheart.00651.2004. Epub 2004 Sep 30. |
arterial blood pressure trait |
male |
52 days-61 days |
0 |
|
|
111.0 |
mmHg |
3.0 |
|
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
138448 |
2801 |
SS/Hsd |
range of heart rate variation during variation of mean arterial blood pressure |
artificial cerebrospinal fluid with 0.15 M sodium (4.4-4.6 ul/hr) (for 14 days) |
Huang BS, et al., Am J Physiol Heart Circ Physiol. 2005 Feb;288(2):H517-24. doi: 10.1152/ajpheart.00651.2004. Epub 2004 Sep 30. |
heart pumping trait |
male |
49 days-56 days |
7 |
|
|
232.0 |
beats/min |
20.0 |
52.92 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
change in heart rate to change in mean arterial blood pressure ratio (range) (CMO:0003896) |
|
138432 |
2801 |
GH/Omr |
change in heart rate to change in vasoactive chemical dose ratio |
angiotensin II (5-50 ng/kg/min) (between 0.2 and 1 hours) then norepinephrine (0.1-1 ug/kg/min) (between 0.2 and 1 hours) then phenylephrine (4 ug/kg) (between 0 and 0 hours) |
Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. |
heart pumping trait |
male |
132 days-146 days |
14 |
|
|
-0.87 |
(beats/min)/(ug/kg) |
0.07 |
0.25 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
ng/kg/min |
change in heart rate to change in vasoactive chemical dose ratio (CMO:0003904), (beats/min)/(ug/kg) |
|
138468 |
101 |
SHR |
diastolic blood pressure |
control condition |
Frantz SA, et al., Hypertension 1998 Oct;32(4):639-46 |
arterial blood pressure trait |
male |
175 days
| 28 |
|
continuous mean |
148.3 |
mmHg |
2.12 |
11.2 |
vascular indwelling catheter method |
aorta |
|
|
0 |
|
|
|
|
11904 |
206 |
SHR.WKY-(D1Wox19-D1Wox34)/Njs |
diastolic blood pressure |
control condition |
Frantz SA, et al., Hypertension 1998 Oct;32(4):639-46 |
arterial blood pressure trait |
male |
175 days
| 31 |
|
continuous mean |
139.2 |
mmHg |
2.25 |
12.5 |
vascular indwelling catheter method |
aorta |
|
|
0 |
|
|
|
|
11909 |
206 |
GH/Omr |
mean arterial blood pressure |
control condition |
Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. |
arterial blood pressure trait |
male |
127 days-143 days |
21 |
|
serial mean |
155.7 |
mmHg |
3.06 |
14.0 |
vascular indwelling catheter method |
left femoral artery and vein |
4 hrs/day for 3 days |
|
0 |
|
microrenathane catheter; recover for 1 week after surgery |
|
|
11521 |
101 |
HTG |
systolic blood pressure |
control condition |
Ueno T, et al., Physiol Genomics 2004 Mar 12;17(1):38-47. |
arterial blood pressure trait |
male |
151 days-181 days |
10 |
|
|
156.4 |
mmHg |
2.1 |
6.64 |
vascular indwelling catheter method |
carotid artery and jugular vein |
|
|
0 |
|
polyethylene catheter |
|
|
11711 |
120 |
BN/NHsdMcwi |
mean arterial blood pressure |
controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (between 22 and 24 days) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
89 days-92 days |
21 |
|
serial mean |
110.0 |
mmHg |
3.0 |
13.75 |
vascular indwelling catheter method |
left femoral artery |
|
|
0 |
|
3 hrs (during inactive phase) 3 consecutive days, and 4 extra hrs (during active phase) next day |
|
|
11853 |
151 |
BN.GH-(D6Mit12-D6Rat15)/Mcwi |
heart rate |
control condition |
Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. |
heart pumping trait |
male |
127 days-143 days |
16 |
|
serial mean |
381.3 |
beats/min |
8.0 |
32.0 |
vascular indwelling catheter method |
left femoral artery and vein |
4 hrs/day for 3 days |
|
0 |
|
microrenathane catheter; recover for 1 week after surgery |
|
|
11538 |
101 |
SS/JrHsdMcwi |
systolic blood pressure |
controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (between 22 and 24 days) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
92 days
| 16 |
|
serial mean |
208.0 |
mmHg |
7.6 |
30.4 |
vascular indwelling catheter method |
left femoral artery |
10800.0 |
|
0 |
|
|
|
|
69510 |
151 |
SS/JrHsdMcwi |
systolic blood pressure |
controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (between 22 and 24 days) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
93 days
| 11 |
|
serial mean |
183.0 |
mmHg |
10.0 |
33.17 |
vascular indwelling catheter method |
left femoral artery |
10800.0 |
|
0 |
|
|
|
|
69516 |
151 |
SS/JrHsdMcwi |
systolic blood pressure |
controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (between 22 and 24 days) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
94 days
| 11 |
|
serial mean |
182.9 |
mmHg |
4.1 |
13.6 |
vascular indwelling catheter method |
left femoral artery |
10800.0 |
|
0 |
|
|
|
|
69522 |
151 |
SS/JrHsdMcwi |
heart rate |
controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (between 22 and 24 days) then controlled exposure to darkness (for 12 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
heart pumping trait |
female |
89 days-91 days |
15 |
|
serial mean |
442.0 |
beats/min |
6.5 |
25.17 |
vascular indwelling catheter method |
left femoral artery |
0.0 |
|
0 |
|
|
|
|
69450 |
151 |
WKY.WKHA-(D5Rat45-D5Rat245)/Cfd |
time constant of left ventricular pressure decay |
artificial aortocaval fistula |
Souzeau E, et al., Hypertension. 2006 Jan;47(1):128-33. Epub 2005 Dec 12. |
heart left ventricular blood pressure trait |
female |
84 days-154 days |
5 |
|
|
12.1 |
ms |
1.9 |
4.25 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
68925 |
1014 |
SD-Trpv1em1Sage+/+ |
heart rate |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
heart pumping trait |
male |
56 days-70 days |
6 |
|
|
345.0 |
beats/min |
6.0 |
14.7 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
104666 |
2988 |
SD-Trpv1em1Sage+/+ |
heart rate |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion then dihydrocapsaicin (1 mg/kg) (for 0.7 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
heart pumping trait |
male |
56 days-70 days |
6 |
|
|
353.0 |
beats/min |
11.0 |
26.94 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
104669 |
2988 |
SD-Trpv1em1Sage+/+ |
heart rate |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion then cyclosporine A (2.5 mg/kg) (for 0.7 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
heart pumping trait |
male |
56 days-70 days |
6 |
|
|
410.0 |
beats/min |
11.0 |
26.94 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
104674 |
2988 |
SD-Trpv1em1Sage+/+ |
heart rate |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion (for 0.2 hours) then cyclosporine A (2.5 mg/kg) (for 0.9 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
heart pumping trait |
male |
56 days-70 days |
6 |
|
|
433.0 |
beats/min |
10.0 |
24.49 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
104701 |
2988 |
SD-Trpv1em1Sage+/+ |
mean arterial blood pressure |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion (for 0.5 hours) then dihydrocapsaicin (0.3 mg/kg) (for 3.2 hours) then Myocardial reperfusion (for 2 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
arterial blood pressure trait |
male |
56 days-70 days |
6 |
|
|
85.0 |
mmHg |
3.0 |
7.35 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
104722 |
2988 |
SD-Trpv1em1Sage+/+ |
mean arterial blood pressure |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion (for 0.5 hours) then V1-Cal (1 mg/kg) (for 3.2 hours) then Myocardial reperfusion (for 2 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
arterial blood pressure trait |
male |
56 days-70 days |
6 |
|
|
85.0 |
mmHg |
4.0 |
9.8 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
104803 |
2988 |
SD-Trpv1em1Sage-/- |
mean arterial blood pressure |
thiobutabarbital (100 mg/kg) then left anterior descending coronary artery occlusion (for 0.5 hours) then V1-Cal (1 mg/kg) (for 3.2 hours) then Myocardial reperfusion (for 2 hours) |
Hurt CM, et al., J Am Heart Assoc. 2016 Sep 26;5(9). pii: JAHA.116.003774. doi: 10.1161/JAHA.116.003774. |
arterial blood pressure trait |
male |
56 days-70 days |
6 |
|
|
84.0 |
mmHg |
8.0 |
19.6 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
104806 |
2988 |
SS/Hsd |
mean arterial blood pressure |
artificial cerebrospinal fluid with 0.15 M sodium (4.4-4.6 ul/hr) (for 14 days) |
Huang BS, et al., Am J Physiol Heart Circ Physiol. 2005 Feb;288(2):H517-24. doi: 10.1152/ajpheart.00651.2004. Epub 2004 Sep 30. |
arterial blood pressure trait |
male |
52 days-61 days |
0 |
|
|
106.0 |
mmHg |
2.0 |
|
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
138381 |
2801 |
WKY/Izm |
absolute change in mean arterial blood pressure |
air-jet exposure (for 0 hours) then candesartan (1 ug) (for 0 hours) |
Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. |
arterial blood pressure trait |
male |
98 days
| 6 |
|
|
0.0 |
mmHg |
2.0 |
4.9 |
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
84552 |
1120 |
SHR |
diastolic blood pressure |
controlled sodium content drinking water (1 %) (for 15 days) |
Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6. |
arterial blood pressure trait |
male |
99 days
| 24 |
|
continuous mean |
144.0 |
mmHg |
2.0 |
9.8 |
vascular indwelling catheter method |
femoral artery |
1800 |
|
0 |
|
pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH) |
|
|
65349 |
306 |
LN/MavRrrc |
absolute change in diastolic blood pressure |
trimethaphan camsylate (10 mg/kg) (for 0.2 hours) |
Vincent M, et al., J Clin Invest 1997 Oct 15;100(8):2000-6 |
arterial blood pressure trait |
not specified |
203 days-217 days |
15 |
|
serial mean |
-43.5 |
mmHg |
1.76 |
6.8 |
vascular indwelling catheter method |
abdominal aorta |
3600 |
|
0 |
|
|
|
|
65265 |
121 |
SHR.WKY-(D1Wox34-D1Rat164)/Njs |
diastolic blood pressure |
control condition |
Frantz S, et al., Hypertension 2001 Aug;38(2):216-21 |
arterial blood pressure trait |
male |
196 days
| 18 |
|
|
135.0 |
mmHg |
2.5 |
10.6 |
vascular indwelling catheter method |
|